OBO_ID (LABEL):	GO_0016020 (membrane)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC184457	8/2003	S45-PMC184457	["caption (fig): figure 1\n\nTransvaginal sonogram image of Intrauterine monochorionic-triamniotic triplet Pregnancy at 9 weeks' Gestational age, demonstrating three separate Embryos, distinct amniotic Membranes (a), and unified Chorion (c)."]	N/A	N/A	[('UBERON_0000051', 'fornix of vagina', 25, 'Transvaginal'), ('UBERON_0022293', 'reproductive gland secretion', 56, 'intrauterine'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('GO_0007565', 'female pregnancy', 125, 'gestational'), ('UBERON_0000922', 'embryo', 171, 'embryos'), ('GO_0016020', 'membrane', 198, 'membranes'), ('UBERON_0003124', 'chorion', 225, 'chorion')]
PMC2526009	10/2008	S189-PMC2526009	['Choline, as a component of structural Phospholipids of Membranes, is necessary for all of these processes.']	N/A	N/A	[('CHEBI_15354', 'choline', 0, 'Choline'), ('CHEBI_16247', 'phospholipid', 38, 'phospholipids'), ('GO_0016020', 'membrane', 55, 'membranes')]
PMC2581757	11/2008	S165-PMC2581757	['Superoxide Generation also perpetuates oxidative stress and Lipid peroxidation through the oxidation of Mitochondrial Iron-Sulphur Clusters such as aconitase, which subsequently stimulate Membrane Phospholipid peroxidation by Alkoxyl Radicals [45].']	N/A	N/A	[('CHEBI_9358', 'Sumatrol', 0, 'Superoxide'), ('GO_0002552', 'serotonin secretion by mast cell', 0, 'Superoxide generation'), ('CHEBI_18059', 'lipid', 60, 'lipid'), ('GO_0005739', 'mitochondrion', 104, 'mitochondrial'), ('CHEBI_24870', 'ion', 118, 'iron'), ('CHEBI_26835', 'sulfur molecular entity', 123, 'sulphur clusters'), ('GO_0016020', 'membrane', 188, 'membrane'), ('CHEBI_16247', 'phospholipid', 197, 'phospholipid'), ('CHEBI_22333', 'alkylating agent', 226, 'alkoxyl'), ('CHEBI_26534', 'retinals', 234, 'radicals')]
PMC2831965	1/2010	S51-PMC2831965	['Iodide Transport is mediated by the Sodium (Na)–Iodide (I) symporter (nis), an integral Membrane protein present in the Thyroid, the Mammary Gland, and other Tissues (vieja et al.']	N/A	N/A	[('CHEBI_5859', 'Icacine', 0, 'Iodide'), ('GO_0042074', 'cell migration involved in gastrulation', 0, 'Iodide transport'), ('CHEBI_52632', 'potassium-39 atom', 36, 'sodium'), ('CHEBI_31894', 'Nandrolone furylpropionate', 44, 'Na)–iodide'), ('CHEBI_51686', 'haematoxylin', 56, 'I'), ('GO_0016020', 'membrane', 88, 'membrane'), ('UBERON_0002046', 'thyroid gland', 120, 'thyroid'), ('UBERON_0001911', 'mammary gland', 133, 'mammary gland'), ('UBERON_0000479', 'tissue', 158, 'tissues')]
PMC2888390	6/2010	S41-PMC2888390	['binding assays, done in triplicate, used 5 μg of resuspended crude Membranes that were incubated with 5 nm[3H]eb for 2–4 h at room temperature.']	N/A	N/A	[('GO_0016020', 'membrane', 67, 'membranes'), ('CHEBI_29238', 'tritium atom', 107, '3H')]
PMC2888390	6/2010	S47-PMC2888390	['briefly, cells were harvested, and crude Membranes were prepared before mixing a fixed amount (20 μg) in gel-loading buffer containing Dithiothreitol and heated to 95 °c for 10–15 min.']	N/A	N/A	[('GO_0016020', 'membrane', 41, 'membranes'), ('CHEBI_18320', '1,4-dithiothreitol', 135, 'dithiothreitol')]
PMC2888390	6/2010	S118-PMC2888390	['each dish was harvested; Membranes were prepared, and [3H]eb was measured/μg of Membrane protein.']	N/A	N/A	[('GO_0016020', 'membrane', 25, 'membranes'), ('CHEBI_29238', 'tritium atom', 55, '3H'), ('GO_0016020', 'membrane', 80, 'membrane')]
PMC2888390	6/2010	S148-PMC2888390	['the relative Expression of Α4 and Β2 protein and [3H]Eb binding was measured in crude Membrane fractions prepared from cells treated with Hc3, Choline ( ch ) or Choline + Hc3 as indicated.']	N/A	N/A	[('GO_0010467', 'gene expression', 13, 'expression'), ('PR_000002123', 'C-C motif chemokine 3', 27, 'α4'), ('PR_000001884', 'macrophage receptor MARCO', 34, 'β2'), ('CHEBI_29238', 'tritium atom', 50, '3H'), ('PR_000007130', 'ephrin type-B receptor 2', 53, 'EB'), ('GO_0016020', 'membrane', 86, 'membrane'), ('CHEBI_17883', 'hydrogen chloride', 138, 'HC3'), ('CHEBI_15354', 'choline', 143, 'choline'), ('CHEBI_15354', 'choline', 161, 'choline'), ('CHEBI_17883', 'hydrogen chloride', 171, 'HC3')]
PMC2888390	6/2010	S154-PMC2888390	['for these measurements, crude Membrane fractions prepared from cultures treated with Choline, Hc3, or both Agents were compared with controls for both Α4 and Β2 Subunit Expression.']	N/A	N/A	[('GO_0016020', 'membrane', 30, 'membrane'), ('CHEBI_15354', 'choline', 85, 'choline'), ('CHEBI_17883', 'hydrogen chloride', 94, 'HC3'), ('CHEBI_33250', 'atom', 107, 'agents'), ('PR_000006890', 'enhancer of mRNA-decapping protein 3', 151, 'α4 ...'), ('PR_000001311', 'adhesion G protein-coupled receptor E5', 158, 'β2 subunit'), ('GO_0010467', 'gene expression', 169, 'expression')]
PMC2888390	6/2010	S171-PMC2888390	['[3H]Eb binding was measured in crude Membrane fractions prepared from cells treated in parallel.']	N/A	N/A	[('CHEBI_29238', 'tritium atom', 1, '3H'), ('PR_000007130', 'ephrin type-B receptor 2', 4, 'EB'), ('GO_0016020', 'membrane', 37, 'membrane')]
PMC2888390	6/2010	S178-PMC2888390	['crude Membranes from cells treated with Choline or Nicotine were prepared for this analysis as described under “experimental procedures.” fractions were collected across the gradient, and the specific [3H]Eb binding profiles are shown.']	N/A	N/A	[('GO_0016020', 'membrane', 6, 'membranes'), ('CHEBI_15354', 'choline', 40, 'choline'), ('CHEBI_25501', 'neoxanthin', 51, 'nicotine'), ('CHEBI_29238', 'tritium atom', 202, '3H'), ('PR_000007130', 'ephrin type-B receptor 2', 205, 'EB')]
PMC2888390	6/2010	S214-PMC2888390	['b , western blot analysis of Α4 or Β2 Expression from crude Membranes of cells treated as indicated.']	N/A	N/A	[('PR_000002123', 'C-C motif chemokine 3', 29, 'α4'), ('PR_000001884', 'macrophage receptor MARCO', 35, 'β2'), ('GO_0010467', 'gene expression', 38, 'expression'), ('GO_0016020', 'membrane', 60, 'membranes')]
PMC2889879	5/2010	S28-PMC2889879	['Neuronal Membranes are largely made up of Phospholipids, and the Brain Phospholipids are rich in polyunsaturated Fatty Acids (pufa).']	N/A	N/A	[('CL_0000540', 'neuron', 0, 'Neuronal'), ('GO_0016020', 'membrane', 9, 'membranes'), ('CHEBI_16247', 'phospholipid', 42, 'phospholipids'), ('UBERON_0000955', 'brain', 65, 'brain'), ('CHEBI_16247', 'phospholipid', 71, 'phospholipids'), ('CHEBI_35366', 'fatty acid', 113, 'fatty acids')]
PMC2889879	5/2010	S159-PMC2889879	['for example, high Intake of Omega-3 Fatty Acids partly replaces Omega-6 Fatty Acids incorporation into Membrane Phospholipids and Omega-3 Fatty Acids have a higher affinity than Omega-6 Fatty Acids for several enzymes [44].']	N/A	N/A	[('GO_0007631', 'feeding behavior', 18, 'intake'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 28, 'omega-3 fatty acids'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 64, 'omega-6 fatty acids'), ('GO_0016020', 'membrane', 103, 'membrane'), ('CHEBI_16247', 'phospholipid', 112, 'phospholipids'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 130, 'omega-3 fatty acids'), ('CHEBI_79370', 'ibho#10', 178, 'omega-6'), ('CHEBI_35366', 'fatty acid', 186, 'fatty acids')]
PMC2999828	3/2009	S20-PMC2999828	['after Degranulation, Mast Cells lose Membrane area, become activated, and start a de novo Synthesis Of Prostaglandins and Leukotrienes from Membrane arachidonic acid [4,5].']	N/A	N/A	[('GO_0043694', 'monoterpene catabolic process', 6, 'degranulation'), ('CL_0000097', 'mast cell', 21, 'mast cells'), ('GO_0016020', 'membrane', 37, 'membrane'), ('GO_0035196', 'production of miRNAs involved in gene silencing by miRNA', 90, 'synthesis of prostaglandins'), ('CHEBI_26333', 'prostaglandin', 103, 'prostaglandins'), ('GO_0007596', 'blood coagulation', 122, 'leukotrienes'), ('GO_0016020', 'membrane', 140, 'membrane')]
PMC3029215	1/2011	S157-PMC3029215	['*affymetrix idgene namefdrfold change (aa vs ca)welch t-test ( p )Gene description205048_s_at "psph"‡04.084 × 10-9phosphoserine phosphatase212777_at Sos1 01.361 × 10-7son of Sevenless Homolog 1202203_s_at Amfr 01.724 × 10-6autocrine motility factor receptor204379_s_at Fgfr3 01.242 × 10-5fibroblast growth factor receptor 3219417_s_at flj20014 00.916 × 10-5chromosome 17 Open Reading Frame 59208416_s_at Sptb 00.911.9 × 10-4spectrin, beta, Erythrocytic206763_At Fkbp6 00.906 × 10-5fk506 binding Partner 6, 36 kda202253_s_at Dnm2 00.902.3 × 10-4Dynamin 2214380_at Prpf31 00.909 × 10-5precursor Mrna-Processing Factor 31, s. cerevisiae, Homolog of213209_at taf6l 00.898 × 10-7taf6-like rna polymerase ii, P300/6cbp associated factor (Pcaf), associated factor, p65216204_at arvcf 00.894 × 10-6armadillo repeat Gene deletes in velocardiofacial syndrome213585_s_at Pdcd2 00.893 × 10-5programmed Cell Death 2201572_x_at dctd 00.892.1 × 10-4Deoxycytidylate deaminase203589_s_at Tfdp2 00.893.3 × 10-4transcription factor Dp-2 (E2F Dimerization Partner 2)211096_at Pbx2 00.883 × 10-6pre B-Cell Leukemia Transcription Factor 2215844_at Tnpo2 00.888 × 10-5transportin 2206182_at Znf134 00.882.3 × 10-4zinc finger protein 134219125_s_at loc55974 00.872 × 10-5Stromal Cell protein201557_at Vamp2 00.876 × 10-5vesicle-Associated Membrane Protein 2 (Synaptobrevin2)202700_s_at kiaa0792 00.871.3 × 10-4transmembrane protein 63a209009_at esd 00.872 × 10-4esterase d200076_s_at mgc2749 00.863 × 10-5hypothetical protein mgc2749207415_at Pla2R1 00.862 × 10-5phospholipase A2 Receptor 1, 180 kda222129_at c2orf17 00.861.6 × 10-4chromosome x Open Reading Frame 17202646_s_at d1s155e 00.851.1 × 10-4cold-shock Domain-containing e1, rna-binding; csde1222199_s_at bin3 00.857 × 10-5bridging integrator 3219939_s_at d1s155e 00.821 × 10-4cold-shock Domain-containing e1, rna-binding; csde1203538_at camlg 00.827 × 10-4Calcium-Modulating cyclophilin ligand208757_at hsgp25l2g 00.811 × 10-6gp25l2 protein218354_at loc51693 00.813.5 × 10-4hematopoietic Stem/progenitor Cells 176204340_at Cxorf12 00.772 × 10-4chromosome x Open Reading Frame 12219599_at Eif4B 00.764 × 10-5eukaryotic Translation Initiation Factor 4B\n*this table shows only those Genes that meet the very high stringency level of fdr = 0 by sam (significance analysis of microarray).']	N/A	N/A	[('SO_0000704', 'gene', 66, 'Gene'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 149, 'SOS1'), ('PR_000014462', 'squamous cell carcinoma antigen recognized by T-cells 3', 174, 'Sevenless Homolog'), ('PR_000003920', 'retinal dehydrogenase 1', 205, 'AMFR'), ('PR_000001450', 'fibroblast growth factor receptor 3', 269, 'FGFR3'), ('SO_0000236', 'ORF', 371, 'Open Reading Frame'), ('PR_000015599', 'protein SPT2', 404, 'SPTB'), ('CL_0002638', 'bronchioalveolar stem cell', 440, 'Erythrocytic206763_at'), ('PR_000007544', 'peptidyl-prolyl cis-trans isomerase FKBP8', 462, 'FKBP6'), ('PR_000014368', 'RuvB-like 1', 495, 'Partner 6'), ('PR_000006564', 'dynein heavy chain 5, axonemal', 524, 'DNM2'), ('PR_000013039', 'POU domain, class 3, transcription factor 2', 543, '4Dynamin'), ('PR_000013270', 'pyridoxal phosphate homeostasis protein PLPBP', 563, 'PRPF31'), ('GO_0006397', 'mRNA processing', 593, 'mRNA-processing'), ('PR_000010299', 'mediator of RNA polymerase II transcription subunit 27', 593, 'mRNA-processing Factor 31'), ('SO_0000853', 'homologous_region', 635, 'Homolog'), ('PR_000005450', 'chromatin accessibility complex protein 1', 703, 'p300'), ('PR_000012443', 'cyclin-dependent kinase 18', 732, 'PCAF'), ('SO_0000704', 'gene', 807, 'Gene'), ('PR_000012493', 'pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial', 860, 'PDCD2'), ('GO_0008219', 'cell death', 890, 'Cell Death'), ('CHEBI_34678', 'Di-n-hexyl phthalate', 933, '4Deoxycytidylate'), ('PR_000016272', 'transcription factor EB', 971, 'TFDP2'), ('PR_000006664', 'dipeptidyl peptidase 9', 1013, 'DP-2'), ('PR_000007140', 'epsin-3', 1019, 'E2F Dimerization Partner 2'), ('GO_0006260', 'DNA replication', 1023, 'Dimerization'), ('PR_000012522', 'all trans-polyprenyl-diphosphate synthase PDSS2', 1056, 'PBX2'), ('CL_0000236', 'B cell', 1078, 'B-cell'), ('PR_000004712', 'breakpoint cluster region protein', 1078, 'B-cell Leukemia Transcription Factor'), ('UBERON_0004608', 'rib 9', 1078, 'B-'), ('PR_000016505', 'troponin I, fast skeletal muscle', 1126, 'TNPO2'), ('PR_000017770', 'zinc finger protein 234', 1168, 'ZNF134'), ('CL_0000848', 'microvillous olfactory receptor neuron', 1246, '5Stromal Cell'), ('PR_000017269', 'ventral anterior homeobox 2', 1277, 'VAMP2'), ('PR_000004806', 'bromodomain-containing protein 2', 1303, '-associated Membrane Protein 2'), ('GO_0016020', 'membrane', 1315, 'Membrane'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 1335, 'Synaptobrevin2'), ('PR_000012809', 'cytosolic phospholipase A2 zeta', 1519, 'PLA2R1'), ('PR_000001194', 'beta-3 adrenergic receptor', 1553, 'A2 Receptor 1'), ('SO_0000236', 'ORF', 1621, 'Open Reading Frame'), ('SO_0000417', 'polypeptide_domain', 1688, 'Domain'), ('SO_0000417', 'polypeptide_domain', 1823, 'Domain'), ('CHEBI_50315', 'chloronium', 1891, '4Calcium'), ('GO_0065007', 'biological regulation', 1900, 'modulating'), ('CL_0000499', 'stromal cell', 2024, 'Stem ... Cells'), ('PR_000030433', 'CKLF-like MARVEL transmembrane domain-containing protein 2', 2059, 'CXorf12'), ('SO_0000236', 'ORF', 2093, 'Open Reading Frame'), ('PR_000006979', 'eukaryotic translation initiation factor 3 subunit G', 2124, 'EIF4B'), ('GO_0006415', 'translational termination', 2154, 'Translation Initiation'), ('PR_000016339', 'T-cell immunoglobulin and mucin domain-containing protein 4', 2154, 'Translation Initiation Factor 4B'), ('SO_0000704', 'gene', 2216, 'genes')]
PMC3031146	1/2011	S70-PMC3031146	['finally, the list of differentially methylated Genes includes four Genes previous shown to be Imprinted ( table 3 ) as well as 14 Mirna Sites ( table 4 ).10.1371/journal.pone.0016506.t002\n\ncaption (table-Wrap): table 2\ntop 50 differentially methylated Genes ranked by statistical significance.symbolgene namegene_idp-value1q-value2chr3cpg islanddirection4ctsl2cathepsin l215151.6e-050.133789yes+Rreb1Ras Responsive Element Binding Protein 162391.6e-050.133786yes+bsnbassoon (Presynaptic cytomatrix protein)89272.2e-050.133783yes+hspc268hypothetical protein hspc2681547914.6e-050.170867yes+Neurog1Neurogenin 147625.5e-050.170865yes+map4k5mitogen-activated protein kinase kinase kinase kinase 5111837.3e-050.1708614yes+ftmtferritin mitochondrial940337.4e-050.170865yes-cpecarboxypeptidase e13638.8e-050.170864yes+Ext2Exostosin 221320.00010.1708611yes+ube3aubiquitin protein ligase e3a73370.000130.1708615yes+dnajb6dnaj (Hsp40) Homolog, Subfamily B, member 6100490.000140.170867yes+uqcrhubiquinol-Cytochrome C reductase hinge protein73880.000140.170861yes+orf1-fl49chromosome 5 Open Reading Frame 32844180.000160.170865yes+H2Afy2H2A Histone Family, Member y2555060.000180.1708610yes+Pkn2Protein kinase n255860.000220.170861yes+Strn3Striatin, Calmodulin Binding Protein 3299660.000220.1708614yes+c8orf35chromosome 8 Open Reading Frame 35551740.000220.170868yes+ndufa7nadh Dehydrogenase (Ubiquinone) 1 alpha subcomplex, 747010.000230.1708619yes-slc36a4solute carrier family 36 (Proton/amino acid Symporter), Member 41201030.000230.1708611yes+c6orf72chromosome 6 Open Reading Frame 721162540.000230.170866yes+c6orf199chromosome 6 Open Reading Frame 1992212640.000250.170866yes+ccdc74acoiled-Coil Domain containing 74a905570.000260.170862yes+Terf1Telomeric Repeat Binding Factor (Nima-Interacting) 170130.000280.170868yes+Snx3Sorting Nexin 387240.000280.170866yes+Hnrph3Heterogeneous Nuclear Ribonucleoprotein H3 (2h9)31890.00030.1708610yes+Cgnl1Cingulin-Like 1849520.000310.1708615yes-itm2bintegral Membrane protein 2b94450.000310.1708613yes+Znf544Zinc Finger Protein 544273000.000320.1708619yes+mgc14376hypothetical protein mgc14376849810.000350.1708617yes+icam3intercellular Adhesion Molecule 333850.000360.1708619no+Rrp22Ras-Related Protein 22106330.000360.1708622yes+Agtpbp1Atp/gtp binding protein 1232870.000370.170869yes+Wnt5Awingless-type Mmtv Integration Site Family, member 5a74740.000370.170863yes+gmdsgdp-Mannose 4,6-dehydratase27620.000390.170866yes+xpr1xenotropic and polytropic retrovirus receptor 192130.00040.170861yes+Gdf3Growth Differentiation Factor 395730.000410.1708612yes+Rasefras and Ef-hand Domain containing1581580.000410.170869yes+Kctd4Potassium channel Tetramerisation Domain containing 43866180.000410.1708613no-rfxapregulatory factor x-Associated protein59940.000410.1708613yes+kcna4potassium voltage-Gated Channel, shaker-related subfamily, member 437390.000420.1708611yes+Egfrepidermal Growth Factor receptor19560.000430.170867yes+lgr6leucine-rich repeat-containing g protein-coupled receptor 6593520.000450.170861yes+Mapk13Mitogen-activated protein kinase 1356030.000470.170866yes+Ssfa2Sperm specific Antigen 267440.000490.170862yes+phcaphytoceramidase, alkaline553310.000490.1708611yes+Tbc1D1Tbc1 (tre-2/Usp6, Bub2, Cdc16) Domain family, member 1232160.000490.170864yes+Lrrc3Bleucine Rich Repeat containing 3b1161350.000490.170863yes+Shcbp1Shc Sh2-Domain Binding Protein 1798010.00050.1708616yes+Pms2Pms2 Postmeiotic Segregation Increased 2 (s. cerevisiae)53950.000530.170867yes+Znf304Zinc Finger Protein 304573430.000530.1708619yes+\np-values were calculated by multiple linear regression and randomization testing (seematerials and methods).']	N/A	N/A	[('SO_0000704', 'gene', 47, 'genes'), ('SO_0000704', 'gene', 67, 'genes'), ('GO_0071514', 'genetic imprinting', 94, 'imprinted'), ('SO_0000147', 'exon', 130, 'miRNA sites'), ('PR_000017453', 'protein Wnt-9b', 204, 'WRAP'), ('SO_0000704', 'gene', 252, 'genes'), ('PR_000014303', 'ribosome-binding protein 1', 395, 'RREB1ras responsive element binding protein'), ('GO_0098793', 'presynapse', 475, 'presynaptic'), ('PR_000011199', 'non-homologous end-joining factor 1', 589, 'NEUROG1neurogenin'), ('PR_000007122', 'ephrin type-A receptor 2', 811, 'EXT2exostosin'), ('PR_000008809', 'heat shock 70 kDa protein 4L', 918, 'Hsp40) homolog, subfamily B,'), ('SO_0000853', 'homologous_region', 925, 'homolog'), ('CHEBI_18070', 'cytochrome c', 994, 'cytochrome c'), ('PR_000002199', 'cytochrome c protein', 994, 'cytochrome c'), ('SO_0000236', 'ORF', 1075, 'open reading frame'), ('PR_000008580', 'histone H2A type 1-A', 1120, 'H2AFY2H2A'), ('CHEBI_15358', 'histone', 1130, 'histone'), ('PR_000008550', '3-hydroxyisobutyryl-CoA hydrolase, mitochondrial', 1130, 'histone family, member'), ('PR_000012774', 'polycystic kidney disease 2-like 1 protein', 1180, 'PKN2protein'), ('PR_000015393', 'suppressor of cytokine signaling 2', 1224, 'STRN3striatin,'), ('PR_000004909', 'complement component C8 beta chain', 1239, 'calmodulin binding protein'), ('SO_0000236', 'ORF', 1312, 'open reading frame'), ('PR_000007123', 'ephrin type-A receptor 3', 1368, 'dehydrogenase ... ubiquinone ... 1'), ('CHEBI_10092', 'Yiamoloside B', 1383, 'ubiquinone'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1469, '36'), ('CHEBI_24636', 'proton', 1473, 'proton'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 1491, 'symporter), member'), ('SO_0000236', 'ORF', 1557, 'open reading frame'), ('SO_0000017', 'PSE_motif', 1624, 'open reading'), ('SO_0001117', 'alpha_helix', 1637, 'frame'), ('SO_0001085', 'sequence_conflict', 1684, '-coil'), ('SO_0000417', 'polypeptide_domain', 1690, 'domain'), ('PR_000016211', 'tectonic-3', 1735, 'TERF1telomeric repeat binding factor'), ('PR_000011151', 'neuralized-like protein 4', 1773, 'NIMA-interacting'), ('PR_000014433', 'scaffold attachment factor B2', 1815, 'SNX3sorting nexin'), ('PR_000005086', 'chromobox protein homolog 5', 1857, 'HNRPH3heterogeneous nuclear ribonucleoprotein H3'), ('SO_0000035', 'riboswitch', 1885, 'ribonucleoprotein'), ('PR_000005589', 'chronic lymphocytic leukemia up-regulated protein 1', 1934, 'CGNL1cingulin-like'), ('GO_0016020', 'membrane', 1993, 'membrane'), ('PR_000017697', 'zinc finger protein 101', 2036, 'ZNF544zinc finger protein'), ('PR_000001858', 'immunoglobulin iota chain', 2171, 'adhesion molecule'), ('CHEBI_36357', 'polyatomic entity', 2180, 'molecule'), ('PR_000014339', 'radial spoke head 14 homolog', 2213, 'RRP22Ras-related protein'), ('PR_000003820', 'putative Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 7', 2265, 'AGTPBP1ATP'), ('PR_000017413', 'WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2', 2321, 'WNT5Awingless'), ('NCBITaxon_10088', 'Mus <genus>', 2340, 'MMTV'), ('PR_000029550', 'interferon-induced protein with tetratricopeptide repeats 1', 2345, 'integration site family,'), ('SO_0000366', 'insertion_site', 2345, 'integration site'), ('CHEBI_67964', 'hopane-6beta,11alpha,22,27-tetraol', 2410, 'mannose 4,6'), ('PR_000007940', 'FAD-linked sulfhydryl oxidase ALR', 2529, 'GDF3growth differentiation factor'), ('PR_000013756', 'Ras-specific guanine nucleotide-releasing factor 1', 2588, 'RASEFRAS'), ('SO_0001318', 'epoxyqueuosine', 2601, 'EF-'), ('SO_0000417', 'polypeptide_domain', 2609, 'domain'), ('PR_000003299', 'lymphocyte antigen 96 isoform 1, signal peptide removed N-glycosylated 1', 2651, 'KCTD4potassium'), ('GO_0010028', 'xanthophyll cycle', 2674, 'tetramerisation'), ('SO_0000417', 'polypeptide_domain', 2690, 'domain'), ('PR_000004593', 'N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3', 2758, '-associated'), ('PR_000000035', 'BMP receptor type-1A', 2823, '-gated channel'), ('PR_000006881', 'proteasome adapter and scaffold protein ECM29', 2897, 'EGFRepidermal growth factor'), ('PR_000010054', 'melanoma-associated antigen 10', 3043, 'MAPK13mitogen'), ('PR_000014753', 'SR-related and CTD-associated factor 4', 3107, 'SSFA2sperm'), ('CHEBI_59132', 'antigen', 3127, 'antigen'), ('PR_000016100', 'TBC1 domain family member 16', 3213, 'TBC1D1TBC1'), ('PR_000017164', 'ubiquitin carboxyl-terminal hydrolase 26', 3231, 'USP6'), ('PR_000004803', 'breast cancer type 1 susceptibility protein', 3237, 'BUB2'), ('PR_000005319', 'cadherin EGF LAG seven-pass G-type receptor 2', 3243, 'cdc16'), ('SO_0000417', 'polypeptide_domain', 3250, 'domain'), ('PR_000004907', 'complement component C7', 3263, ','), ('PR_000029594', 'protein lifeguard 3', 3297, 'LRRC3Bleucine rich repeat'), ('PR_000014803', 'N-sulphoglucosamine sulphohydrolase', 3361, 'SHCBP1SHC'), ('PR_000014740', 'splicing factor 4', 3371, 'SH2-domain binding protein'), ('SO_0000417', 'polypeptide_domain', 3375, 'domain'), ('PR_000014700', 'serpin B9', 3423, 'PMS2PMS2'), ('GO_0009805', 'coumarin biosynthetic process', 3432, 'postmeiotic'), ('PR_000012529', 'PDZK1-interacting protein 1', 3432, 'postmeiotic segregation increased 2'), ('PR_000017816', 'zinc finger protein 300', 3506, 'ZNF304zinc finger protein')]
PMC3131279	7/2011	S57-PMC3131279	['no other Genes were among the twenty most altered Genes in more than one generation.10.1371/journal.pone.0021668.t001\n\ncaption (table-Wrap): table 1\nHepatic Genes showing the greatest difference between pr and ps offspring.difference between ps and pr offspring (fold differences between pr and ps)f1f2f3up-regulateddown-regulatedup-regulateddown-regulatedup-regulateddown-regulatedcytochrome P450, 3,A nm_153312 (69.4)Transmembrane Protein 27 nm_020976 (174.3) Trefoil Factor 2 nm_053844 (13.9) Olfactory receptor 144 nm_001000164 (15.3)Surfactant associated protein c nm_017342 (25.1)Pancreatic Lipase Related Protein 1 nm_032081 (47.5)α2μ globulin nm_001024248 (40.2)Uromodulin nm_017082 (105.3)Hyaluronan mediated motility receptor nm_012964 (12.9)Egf-Like Domain 7 nm_139104 (14) Lymphocyte-Activation Gene 3 nm_212513 (17.4) Pancreatic lipase nm_013161 (39.6)α2μ globulin Pgcl4 nm_147215 (38.3)Cytochrome P450 (11B) nm_012537 (104.9)Sarcolipin nm_001013247 (10.0)Type i keratin Ka11 nm_001008750 (7.1)Caveolin 3 nm_019155 (11.2) Pancreatic Amylase 2 nm_031502 (39.4)Lymphocyte-Activation Gene 3 nm_212513 (35.9) Chromogranin B nm_012526 (98.8)Cathepsin R nm_001017509 (7.9)T-Cell receptor Β-Chain mrna v-region m23885 (6.6)Telethonin xm_001081394 (9.9)Glycoprotein 2 nm_134418 (38.5)Α2Μ Globulin Pgcl3 nm_147212 (29.1)Chloride channel kb nm_173103 (98.1)Threonyl-Trna Synthetase-Like 2 nm_001014020 (7.6)Stathmin-Like 3 nm_024346 (5.5)Bile Acid Coenzyme A: amino acid n-acyltransferasexm_001055067 (9.7)Cationic Trypsinogen nm_173127 (34.4)α2μ globulin Pgcl1 nm_147214 (16.4)Solute Carrier Family 7 (y+ system) member 13 nm_001012100 (92.6) Lymphocyte-Activation Gene 3 nm_212513 (7.5) Myelin-Associated Basic Protein-99 X89638 (5.2)riken nm_001039686 (7.9)Serine Protease-2 nm_012729 (26.0)myosin ixb xm_346173 (15.2)Defensin Β1 nm_031810 (81.4)C-Myc Promoter binding protein xr_009072 (7.3)Cystatin nm_133566 (5.0)Myosin, Light Polypeptide 3 nm_012606 (7.9)Pancreatic Trypsin 1 nm_012635 (24.8)α2μ globulin Pgcl5 nm_147213 (12.8)Solute Carrier Family 26 (4) nm_019214 (80.1)Gastrokine 1 Xm_001074955 (6.4)Socs Box-Containing Protein 3 Xm_344277 (4.5)Immunoglobulin variable region z93370 (7.8)Pancreatic lipase-related Protein-2 nm_057206 (22.5)Caldesmon 1 nm_013146 (12.3)Protein Phosphatase 1, Regulatory Subunit 1A nm_022676 (76.6)Membrane-associated dhhc17 zinc finger protein nm_001039340 (5.8)Fun14 Domain Containing-1 nm_001025027 (4.5)Pancreatitis-Associated Protein nm_053289 (7.8)Ribonuclease A nm_001029904 (19.8)Major Urinary Protein 5 nm_203325 (11.3)Solute Carrier Family 3 nm_017216 (71.0)unknown af433878 (5.3)arachidonate 5-lipoxygenase nm_012822 (4.5)Actin-Α Cardiac- 1 nm_019183 (7.7)Chymotrypsin C nm_001077649 (19.1)Cytochrome P450 (2C13) nm_138514 (10.4)Kidney Androgen Regulated Protein nm_052802 (67.6)Glycosylation Dependent Cell Adhesion Molecule 1 nm_012794 (5.2)Protocadherin-Α nm_201422 (4.5)Ec1-V2R Pheromone Receptor Xm_236825 (7.0)Pancreatic Elastase-1 nm_012552 (18.9)α2μ globulin (l type) nm_001003409 (10.1)Deoxyribonuclease 1 nm_013097 (60.8)Actin Α Cardiac 1 nm_019183 (5.2)Thioesterase Superfamily Member 4 (Them4), mrna nm_001025017 (4.4)S100 Calcium Binding protein g nm_012521 (7.0)Chymotrypsin-Like nm_054009 (17.0)Kpl2 protein nm_022620 (10.0)Degenerative Spermatocyte Homolog 2 nm_001017457 (58.0)serine dehydratase x13119 (5.0)Endothelial differentiation, Sphingolipid G-Protein-Coupled Receptor, 8 nm_021775 (4.3) Trefoil Factor 2 nm_053844 (6.9) Carboxypeptidase B1 nm_012533 (16.5)Cytochrome P450 (iic) nm_019184 (8.1)solute carrier family 5 (Sodium/Glucose co-Transporter), nm_022590 (57.6)phosphodiesterase 4d interacting protein nm_022382 (4.9)Olfactory Receptor 74 nm_001000134 (4.3)Type i keratin Ka15 nm_001004022 (6.9)Trypsin 10 nm_001004097 (16.5)protein tyrosine kinase c-yes xm_343644 (7.5)Tonin nm_012677 (49.7)Olfactory receptor 1250 nm_001000806 (4.8)Olfactory Receptor 821 nm_001000842 (4.3)Topoisomerase -2Α nm_022183 (6.7)chymotrypsinogen b nm_012536 (15.1)Diamine Acetyltransferase 1 Xm_228448 (7.0)myosin, heavy polypeptide 7 nm_017240 (48.1)pparγ1 co-activator 1α nm_031347 (4.6)Kiss1 receptor nm_023992 (4.2)cleavage and Polyadenylation specificity Factor 3 Xr_005746 (6.3)Elastase 2 nm_012553 (11.9) Pancreatic Amylase 2 nm_031502 (6.8) Cadherin 16 nm_001012055 (47.6)Olfactory receptor 1467 nm_001000025 (4.6)Calmodulin-sensitive Plasma Membrane Ca2+-Transporting atpase j05087 (4.2)atp-binding Cassette (Sub-Family B, Member 11) xm_579531 (6.2)Pancreatic colipase nm_013139 (10.6)absent 1 Isoform b xm_232591 (6.8)Solute Carrier Family 7 (y+ system), member 12 nm_001017465 (47.1)Cysteine And Tyrosine-Rich Protein 1 nm_001013980 (4.6)Seminal Vesicle Protein 4 nm_012662 (4.1)Annexin A8 nm_001031654 (6.1)syncollin nm_139086 (9.4)Glandular Kallikrein 11 nm_001003977 (5.5)Hydroxyacid Oxidase-2 nm_032082 (45.1)Neurogenic Differentiation- 2 nm_019326 (4.6)Rt1 class ib Gene nm_012646 (4.1)Olfactory receptor 272 nm_001000230 (6.0)serpin x99773 (9.2)Rab3A nm_013018 (5.5)Solute Carrier Family 12, Member 1 nm_019134 (41.9)Rt1 Class Ii, locus dob nm_001008846 (4.3)Dual Oxidase 1 nm_153739 (4.1)lectin, Galactose binding, soluble 4 nm_012975 (5.8)Carboxyl Ester lipase nm_016997 (9.2)\nGenes which were among the twenty most different between pr and ps offspring in more than one generation are in bold font.']	N/A	N/A	[('SO_0000704', 'gene', 9, 'genes'), ('SO_0000704', 'gene', 50, 'genes'), ('PR_000017453', 'protein Wnt-9b', 134, 'WRAP'), ('UBERON_0002107', 'liver', 149, 'Hepatic'), ('SO_0000704', 'gene', 157, 'genes'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 393, 'P450'), ('PR_000013139', "serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha", 393, 'P450, 3,a'), ('GO_0032588', 'trans-Golgi network membrane', 419, 'Transmembrane'), ('PR_000029823', 'E3 ubiquitin ligase TRIM40', 419, 'Transmembrane protein 27'), ('PR_000016470', 'transmembrane and ubiquitin-like domain-containing protein 1', 462, 'Trefoil factor 2'), ('GO_0007608', 'sensory perception of smell', 496, 'Olfactory'), ('CHEBI_35195', 'surfactant', 538, 'Surfactant'), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 586, 'Pancreatic lipase related protein 1'), ('UBERON_0001264', 'pancreas', 586, 'Pancreatic'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 670, 'Uromodulin'), ('CHEBI_5828', 'Hymexazol O-glucoside', 698, 'Hyaluronan'), ('PR_000006911', 'selenocysteine-specific elongation factor', 752, 'EGF-like domain 7'), ('SO_0000417', 'polypeptide_domain', 761, 'domain'), ('CL_0000824', 'mature natural killer cell', 785, 'Lymphocyte'), ('GO_0036364', 'transforming growth factor beta1 activation', 785, 'Lymphocyte-activation'), ('PR_000009658', 'laminin subunit gamma-1', 785, 'Lymphocyte-activation gene 3'), ('SO_0000704', 'gene', 807, 'gene'), ('UBERON_0001264', 'pancreas', 831, 'Pancreatic'), ('PR_000012388', 'protocadherin gamma-A10', 878, 'PGCL4'), ('CHEBI_4056', 'cytochrome', 900, 'Cytochrome'), ('PR_000006137', 'cytochrome P450 4B1', 900, 'Cytochrome P450'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 917, '11B'), ('PR_000000364', 'smad2', 939, 'Sarcolipin'), ('PR_000016580', 'tropomyosin beta chain', 969, 'Type'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 984, 'KA11'), ('PR_000004967', 'calbindin', 1007, 'Caveolin 3'), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 1035, 'Pancreatic amylase 2'), ('UBERON_0001264', 'pancreas', 1035, 'Pancreatic'), ('CL_0000824', 'mature natural killer cell', 1072, 'Lymphocyte'), ('GO_0036364', 'transforming growth factor beta1 activation', 1072, 'Lymphocyte-activation'), ('PR_000009658', 'laminin subunit gamma-1', 1072, 'Lymphocyte-activation gene 3'), ('SO_0000704', 'gene', 1094, 'gene'), ('CHEBI_68805', 'chaetomugilin A', 1118, 'Chromogranin B'), ('PR_000001204', 'C-C chemokine receptor type 8', 1149, 'Cathepsin R'), ('CL_0000084', 'T cell', 1179, 'T-cell'), ('PR_000003676', 'actin, cytoplasmic 1', 1195, 'β-chain'), ('PR_000016393', 'transmembrane channel-like protein 2', 1229, 'Telethonin'), ('CHEBI_17089', 'glycoprotein', 1258, 'Glycoprotein'), ('PR_000007898', 'glutamate--cysteine ligase regulatory subunit', 1258, 'Glycoprotein 2'), ('PR_000001990', 'C-C motif chemokine 18', 1289, 'α2μ'), ('CHEBI_5386', 'globin', 1293, 'globulin'), ('PR_000012591', 'pepsin A-5', 1302, 'PGCL3'), ('CHEBI_17996', 'chloride', 1324, 'Chloride'), ('PR_000016296', 'protein-glutamine gamma-glutamyltransferase 5', 1360, 'Threonyl-tRNA synthetase-like 2'), ('PR_000015293', 'sphingomyelin phosphodiesterase 2', 1410, 'Stathmin-like 3'), ('CHEBI_3098', 'bile acid', 1441, 'Bile acid'), ('UBERON_0001970', 'bile', 1441, 'Bile'), ('CHEBI_15346', 'coenzyme A', 1451, 'Coenzyme A'), ('CHEBI_36916', 'cation', 1509, 'Cationic'), ('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 1518, 'trypsinogen'), ('PR_000013059', 'peroxisome proliferator-activated receptor gamma coactivator 1-alpha', 1559, 'PGCL1'), ('PR_000015439', 'nuclear body protein SP140-like protein', 1581, 'Solute carrier family 7 ...'), ('CL_0000824', 'mature natural killer cell', 1647, 'Lymphocyte'), ('PR_000004680', 'breast carcinoma-amplified sequence 3', 1657, '-activation gene 3'), ('SO_0000704', 'gene', 1669, 'gene'), ('PR_000029266', 'alkylglycerol monooxygenase', 1692, 'Myelin-associated Basic Protein-99 X89638'), ('UBERON_0000345', 'myelin', 1692, 'Myelin'), ('PR_000014506', 'secretoglobin family 1D member 1', 1763, 'Serine protease-2'), ('PR_000006525', 'delta-like protein 4', 1824, 'Defensin β1'), ('PR_000000084', 'c-myc protein', 1852, 'C-myc'), ('SO_0000167', 'promoter', 1858, 'promoter'), ('PR_000005890', 'crooked neck-like protein 1', 1898, 'Cystatin'), ('PR_000010876', 'myoferlin', 1922, 'Myosin, light polypeptide 3'), ('PR_000014709', 'neuroserpin', 1965, 'Pancreatic'), ('UBERON_0001264', 'pancreas', 1965, 'Pancreatic'), ('PR_000027795', 'trypsin', 1976, 'trypsin 1'), ('PR_000012388', 'protocadherin gamma-A10', 2015, 'PGCL5'), ('PR_000015229', 'solute carrier organic anion transporter family member 4A1', 2037, 'Solute carrier family 26'), ('PR_000007220', 'ethanolamine kinase 2', 2082, 'Gastrokine 1 XM_001074955'), ('PR_000029264', 'AT-hook DNA-binding motif-containing protein 1', 2113, 'SOCS box-containing protein 3 XM_344277'), ('GO_0019815', 'B cell receptor complex', 2158, 'Immunoglobulin'), ('UBERON_0001264', 'pancreas', 2201, 'Pancreatic'), ('PR_000014700', 'serpin B9', 2227, 'protein-2'), ('PR_000002199', 'cytochrome c protein', 2253, 'Caldesmon 1'), ('PR_000013086', 'peptidyl-prolyl cis-trans isomerase-like 4', 2281, 'Protein phosphatase 1, regulatory subunit 1A'), ('GO_0065007', 'biological regulation', 2304, 'regulatory'), ('GO_0016020', 'membrane', 2342, 'Membrane'), ('PR_000007693', 'ferritin, mitochondrial', 2407, 'FUN14 domain containing-1'), ('SO_0000417', 'polypeptide_domain', 2413, 'domain'), ('PR_000013199', 'prolargin', 2451, 'Pancreatitis-associated protein'), ('PR_000023799', 'ribonuclease R', 2498, 'Ribonuclease A'), ('PR_000010045', 'transcription factor Maf', 2532, 'Major urinary protein 5'), ('UBERON_0001088', 'urine', 2538, 'urinary'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 2572, 'Solute carrier family 3'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 2677, 'Actin-α cardiac- 1'), ('UBERON_0000948', 'heart', 2685, 'cardiac'), ('PR_000006022', 'lysosomal protective protein', 2711, 'Chymotrypsin C'), ('CHEBI_4056', 'cytochrome', 2745, 'Cytochrome'), ('PR_000006137', 'cytochrome P450 4B1', 2745, 'Cytochrome P450'), ('PR_000005173', 'CD59 glycoprotein', 2762, '2c13'), ('PR_000009204', 'lysine-specific demethylase 5A', 2784, 'Kidney androgen regulated protein'), ('UBERON_0002113', 'kidney', 2784, 'Kidney'), ('CHEBI_50113', 'androgen', 2791, 'androgen'), ('GO_0065007', 'biological regulation', 2800, 'regulated'), ('GO_0006277', 'DNA amplification', 2834, 'Glycosylation'), ('PR_000007775', 'gamma-aminobutyric acid receptor subunit delta', 2834, 'Glycosylation dependent cell adhesion molecule 1'), ('CHEBI_36357', 'polyatomic entity', 2872, 'molecule'), ('PR_000012194', 'P2X purinoceptor 7', 2898, 'Protocadherin-α'), ('PR_000006897', 'endothelin-1', 2929, 'EC1-'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 2933, 'V2R pheromone receptor XM_236825'), ('PR_000012529', 'PDZK1-interacting protein 1', 2971, 'Pancreatic elastase-1'), ('UBERON_0001264', 'pancreas', 2971, 'Pancreatic'), ('PR_000006605', 'dynamin-binding protein', 3050, 'Deoxyribonuclease 1'), ('PR_000003564', 'ATP-binding cassette sub-family C member 9', 3086, 'Actin α cardiac 1'), ('UBERON_0000948', 'heart', 3094, 'cardiac'), ('PR_000016139', 'TATA box-binding protein-like 2', 3119, 'Thioesterase superfamily member 4'), ('PR_000016329', 'T-lymphoma invasion and metastasis-inducing protein 2', 3154, 'Them4'), ('PR_000014411', 'protein S100-A4', 3185, 'S100 calcium binding'), ('PR_000005875', 'cysteine-rich protein 3', 3231, 'Chymotrypsin-like'), ('PR_000009329', 'killer cell immunoglobulin-like receptor 2DL3', 3265, 'KPL2'), ('PR_000006460', 'dihydroorotate dehydrogenase (quinone), mitochondrial', 3294, 'Degenerative spermatocyte homolog 2'), ('CL_0000017', 'spermatocyte', 3307, 'spermatocyte'), ('SO_0000853', 'homologous_region', 3320, 'homolog'), ('UBERON_0001986', 'endothelium', 3380, 'Endothelial'), ('CHEBI_26739', 'sphingolipid', 3409, 'sphingolipid'), ('PR_000001703', 'mas-related G-protein coupled receptor X2', 3409, 'sphingolipid G-protein-coupled receptor, 8'), ('PR_000016470', 'transmembrane and ubiquitin-like domain-containing protein 1', 3468, 'Trefoil factor 2'), ('PR_000005347', 'centrosome-associated protein CEP250', 3501, 'Carboxypeptidase B1'), ('CHEBI_4056', 'cytochrome', 3537, 'Cytochrome'), ('PR_000006137', 'cytochrome P450 4B1', 3537, 'Cytochrome P450'), ('CHEBI_52632', 'potassium-39 atom', 3599, 'sodium'), ('CHEBI_17234', 'glucose', 3606, 'glucose'), ('PR_000014938', 'urea transporter 1', 3617, 'transporter'), ('GO_0007608', 'sensory perception of smell', 3703, 'Olfactory'), ('PR_000014368', 'RuvB-like 1', 3713, 'receptor'), ('PR_000016580', 'tropomyosin beta chain', 3743, 'Type'), ('PR_000009486', 'keratin, type II cytoskeletal 71', 3758, 'KA15'), ('PR_000016869', 'thioredoxin-like protein 4A', 3781, 'Trypsin 10'), ('PR_000016331', 'tigger transposable element-derived protein 1', 3856, 'Tonin'), ('GO_0007608', 'sensory perception of smell', 3878, 'Olfactory'), ('GO_0007608', 'sensory perception of smell', 3920, 'Olfactory'), ('PR_000029714', 'roquin-2', 3930, 'receptor 821'), ('PR_000016842', 'trafficking regulator of GLUT4 1', 3961, 'Topoisomerase -2α'), ('CHEBI_4514', 'dicyclomine', 4029, 'Diamine'), ('PR_000029427', 'DnaJ homolog subfamily C member 7', 4029, 'Diamine acetyltransferase 1 XM_228448'), ('PR_000009329', 'killer cell immunoglobulin-like receptor 2DL3', 4154, 'KISS1'), ('GO_0043631', 'RNA polyadenylation', 4197, 'polyadenylation'), ('PR_000049700', 'protein Wnt-9b, signal peptide removed form (human)', 4225, 'factor 3 XR_005746'), ('PR_000007002', 'eukaryotic translation initiation factor 5', 4249, 'Elastase 2'), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 4277, 'Pancreatic amylase 2'), ('UBERON_0001264', 'pancreas', 4277, 'Pancreatic'), ('PR_000004968', 'calretinin', 4314, 'Cadherin 16'), ('GO_0007608', 'sensory perception of smell', 4345, 'Olfactory'), ('PR_000004967', 'calbindin', 4387, 'Calmodulin'), ('GO_0005886', 'plasma membrane', 4408, 'plasma membrane'), ('CHEBI_81233', 'Schizonepetoside B', 4424, 'Ca2+-'), ('GO_0016554', 'cytidine to uridine editing', 4424, 'Ca2+-transporting'), ('SO_0005853', 'gene_cassette', 4473, 'cassette'), ('PR_000015900', 'putative synaptotagmin-14-like protein', 4483, 'sub-family B, member 11'), ('UBERON_0001264', 'pancreas', 4523, 'Pancreatic'), ('SO_0001060', 'sequence_variant', 4568, 'isoform'), ('PR_000015439', 'nuclear body protein SP140-like protein', 4593, 'Solute carrier family 7 ...'), ('PR_000005866', 'cAMP-responsive element modulator', 4659, 'Cysteine and tyrosine-rich protein 1'), ('PR_000014892', 'NAD-dependent protein deacetylase sirtuin-6', 4714, 'Seminal vesicle protein 4'), ('UBERON_0000997', 'mammalian vulva', 4714, 'Seminal'), ('PR_000004080', 'annexin A7', 4755, 'Annexin A8'), ('UBERON_0002530', 'gland', 4809, 'Glandular'), ('PR_000009309', 'kinesin-like protein KIF2B', 4819, 'kallikrein 11'), ('CHEBI_16240', 'hydrogen peroxide', 4851, 'Hydroxyacid'), ('PR_000008453', 'hepatitis A virus cellular receptor 1', 4851, 'Hydroxyacid oxidase-2'), ('GO_0001822', 'kidney development', 4889, 'Neurogenic'), ('PR_000011461', 'endonuclease III-like protein 1', 4889, 'Neurogenic differentiation- 2'), ('PR_000012993', 'DNA-directed RNA polymerase II subunit RPB7', 4934, 'RT1'), ('SO_0000704', 'gene', 4947, 'gene'), ('GO_0007608', 'sensory perception of smell', 4967, 'Olfactory'), ('PR_000013610', 'Ras-related protein Rab-34', 5027, 'RAB3A'), ('PR_000015229', 'solute carrier organic anion transporter family member 4A1', 5048, 'Solute carrier family 12, member 1'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 5099, 'RT1 class II'), ('PR_000006745', 'dual specificity protein phosphatase 19', 5141, 'Dual oxidase 1'), ('CHEBI_28260', 'galactose', 5179, 'galactose'), ('CHEBI_3385', 'carbachol', 5223, 'Carboxyl ester'), ('SO_0000704', 'gene', 5261, 'Genes')]
PMC3156909	9/2011	S49-PMC3156909	['for Cd36 quantification by immunoblotting, 4 µg and 6 µg of Cytosolic and Membrane extracts, respectively, were loaded and probed with 1/1000 Rabbit polyclonal anti-Cd36 Antibody (novus biologicals, inc. littleton, co, usa).']	N/A	N/A	[('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 4, 'CD36'), ('GO_0005829', 'cytosol', 60, 'cytosolic'), ('GO_0016020', 'membrane', 74, 'membrane'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 142, 'rabbit'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 165, 'CD36'), ('GO_0042571', 'immunoglobulin complex, circulating', 170, 'antibody')]
PMC3156909	9/2011	S97-PMC3156909	['( c ) immunoblot quantification of the Membrane-bound Cd36 protein in muscle and mrna Expression of marker Genes for Fatty Acid Transport and oxidation measured in Gastrocnemius 10 months after lipistase treatment (* p<0.05).']	N/A	N/A	[('GO_0016020', 'membrane', 39, 'membrane'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 54, 'CD36'), ('GO_0010467', 'gene expression', 86, 'expression'), ('SO_0000704', 'gene', 107, 'genes'), ('CHEBI_35366', 'fatty acid', 117, 'fatty acid'), ('GO_0015908', 'fatty acid transport', 117, 'fatty acid transport'), ('UBERON_0001388', 'gastrocnemius', 164, 'gastrocnemius')]
PMC3219760	10/2011	S42-PMC3219760	['Iron, in its reduced form, enters the Enterocyte Cytoplasm by means of a Membrane transporter.']	N/A	N/A	[('CHEBI_24870', 'ion', 0, 'Iron'), ('CL_0000584', 'enterocyte', 38, 'enterocyte'), ('GO_0005737', 'cytoplasm', 49, 'cytoplasm'), ('GO_0016020', 'membrane', 73, 'membrane')]
PMC3264579	1/2012	S72-PMC3264579	['after detection of the phosphorylated protein, Membranes were stripped using a Tris ph 6.8 50 mm, 2-Mercaptoethanol 100 mm and Sds 2% Solution and re-blotted with the Rabbit anti-Stat3 (1∶1000), and Rabbit anti-mtor (1∶1000), Rabbit anti-Akt (1∶2000) (cell signaling technology for all Antibodies, ozyme, st quentin en yvelines).']	N/A	N/A	[('GO_0016020', 'membrane', 47, 'membranes'), ('CHEBI_9754', 'tris', 79, 'Tris'), ('CHEBI_41218', 'mercaptoethanol', 98, '2-mercaptoethanol'), ('CHEBI_8984', 'sodium dodecyl sulfate', 127, 'SDS'), ('CHEBI_75958', 'solution', 134, 'solution'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 167, 'rabbit'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 179, 'STAT3'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 199, 'rabbit'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 226, 'rabbit'), ('PR_000003888', 'A-kinase anchor protein 14', 238, 'AKT'), ('GO_0042571', 'immunoglobulin complex, circulating', 286, 'antibodies')]
PMC3270452	1/2012	S14-PMC3270452	['La is converted into arachidonic acid (Aa), a Membrane component and a precursor to Signaling Molecules [2].']	N/A	N/A	[('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 0, 'LA'), ('CHEBI_27718', "alpha-Fuc-(1->2)-[alpha-Fuc-(1->2)-beta-Gal-(1->3)-alpha-GalNAc-(1->3)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer", 39, 'AA'), ('GO_0016020', 'membrane', 46, 'membrane'), ('CHEBI_62488', 'signalling molecule', 84, 'signaling molecules')]
PMC3270452	1/2012	S20-PMC3270452	['Dha is actively and preferentially transferred to the fetus by specific Fatty Acid Placental transfer and Membrane binding proteins.']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 0, 'DHA'), ('CHEBI_35366', 'fatty acid', 72, 'fatty acid'), ('UBERON_0001987', 'placenta', 83, 'placental'), ('GO_0016020', 'membrane', 106, 'membrane')]
PMC3276988	9/2011	S66-PMC3276988	['they are Membrane bound Molecules with a peptide binding Domain that interacts with the “T” Cell receptor.']	N/A	N/A	[('GO_0016020', 'membrane', 9, 'membrane'), ('CHEBI_36357', 'polyatomic entity', 24, 'molecules'), ('SO_0000417', 'polypeptide_domain', 57, 'domain'), ('CL_0000984', 'IgA plasmablast', 89, 'T ... cell')]
PMC3321448	3/2012	S28-PMC3321448	['the receptors then translocate from the Plasma Membrane into Vesicular Cytosolic compartments and either targeted for degradation or dephosphorylation and recycled back to the Membrane.']	N/A	N/A	[('GO_0005886', 'plasma membrane', 40, 'plasma membrane'), ('GO_0031982', 'vesicle', 61, 'vesicular'), ('GO_0005829', 'cytosol', 71, 'cytosolic'), ('GO_0016020', 'membrane', 176, 'membrane')]
PMC3321448	3/2012	S52-PMC3321448	['western blot analysis\nHearts collected for western blot analysis from the langendorff study were used to prepare Cardiac Membrane and Cytosolic fractionated samples as described by fernandez-Twinn and colleagues [20].']	N/A	N/A	[('UBERON_0000948', 'heart', 22, 'Hearts'), ('UBERON_0000948', 'heart', 113, 'cardiac'), ('GO_0016020', 'membrane', 121, 'membrane'), ('GO_0005829', 'cytosol', 134, 'cytosolic'), ('PR_000016829', 'gamma-tubulin complex component 4', 191, 'Twinn')]
PMC3321448	3/2012	S60-PMC3321448	['Membranes were incubated in blocking Solution (5% dried skimmed milk in tbs with 1% Tween 20) prior to incubation with primary Antibodies.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('CHEBI_75958', 'solution', 37, 'solution'), ('CHEBI_53424', 'polysorbate 20', 84, 'Tween 20'), ('GO_0042571', 'immunoglobulin complex, circulating', 127, 'antibodies')]
PMC3321448	3/2012	S89-PMC3321448	['Expression was measured in both Membrane (figure 1) and Cytosolic (figure 2) fractions prepared from each Heart.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('GO_0016020', 'membrane', 32, 'membrane'), ('GO_0005829', 'cytosol', 56, 'cytosolic'), ('UBERON_0000948', 'heart', 106, 'heart')]
PMC3321454	3/2012	S87-PMC3321454	['measurement of Proton conductance\nTriphenylmethylphosphonium (tpmp), the potential sensitive probe was used to measure Membrane potential by detecting the external tpmp in the medium.']	N/A	N/A	[('CHEBI_34934', 'prometon', 15, 'Proton'), ('CHEBI_9720', 'Trihexyphenidyl', 34, 'Triphenylmethylphosphonium'), ('GO_0016020', 'membrane', 119, 'membrane')]
PMC3321454	3/2012	S91-PMC3321454	['Membrane potential and oxygen consumption were progressively inhibited through successive steady states using up to 4\u2009mm Malonate [22].']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membrane'), ('CHEBI_31794', 'magnesium oxide', 121, 'Malonate')]
PMC3401547	7/2012	S26-PMC3401547	['Placental Amino Acids transporters are present both at the Microvillous and basal Membrane levels.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('CHEBI_33867', 'idonates', 10, 'amino acids'), ('GO_1990742', 'microvesicle', 59, 'microvillous'), ('UBERON_0001571', 'genioglossus muscle', 59, 'microvillous'), ('GO_0016020', 'membrane', 82, 'membrane')]
PMC3403156	7/2012	S59-PMC3403156	['targets of oxidative stress include Phospholipid Membranes, proteins, and Nucleic acids [58].']	N/A	N/A	[('CHEBI_16247', 'phospholipid', 36, 'phospholipid'), ('GO_0016020', 'membrane', 49, 'membranes'), ('GO_0005634', 'nucleus', 74, 'nucleic')]
PMC3404662	4/2012	S96-PMC3404662	['in Adults, gabaareceptor activation promotes Chloride influx and hyperpolarization of the Membrane, decreasing Neuronal excitability.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 3, 'adults'), ('CHEBI_17996', 'chloride', 45, 'chloride'), ('GO_0016020', 'membrane', 90, 'membrane'), ('CL_0000540', 'neuron', 111, 'neuronal')]
PMC3407995	7/2012	S39-PMC3407995	['Dha and aa are highly concentrated in Membrane Phospholipids of the Retina and Brain, where they accumulate rapidly during foetal and infant growth spurts [6,7].']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 0, 'DHA'), ('GO_0016020', 'membrane', 38, 'membrane'), ('CHEBI_16247', 'phospholipid', 47, 'phospholipids'), ('UBERON_0000966', 'retina', 68, 'retina'), ('UBERON_0000955', 'brain', 79, 'brain')]
PMC3411795	8/2012	S47-PMC3411795	['Membranes were then washed with 1× pbst and incubated with Alexa 680 conjugated goat anti-Mouse Antibody (1∶20,000, invitrogen) at room temperature for 1 h. Membranes were washed again with 1× pbst for 3 times and then scanned under odyssey imager (li-cor bioscience, usa).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('CHEBI_51766', 'Alexa Fluor 568', 59, 'Alexa 680'), ('NCBITaxon_10088', 'Mus <genus>', 90, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 96, 'antibody'), ('GO_0016020', 'membrane', 157, 'Membranes')]
PMC3423345	8/2012	S116-PMC3423345	['large amounts of Choline are also needed to support new Membrane Synthesis associated with Cell Division and growth.']	N/A	N/A	[('CHEBI_15354', 'choline', 17, 'choline'), ('GO_0016020', 'membrane', 56, 'membrane'), ('GO_0030397', 'membrane disassembly', 56, 'membrane synthesis'), ('GO_0051301', 'cell division', 91, 'cell division')]
PMC3424155	8/2012	S74-PMC3424155	['after blocking, the Membranes were incubated with the follow Antibodies: a) polyclonal Antibody against Rabbit anti-Human At1 Receptor (At1R 306; 43 kda; sc-579; 1∶1000; santa cruz biotechnology); b) monoclonal Antibody against Mouse Renin (A-1; 38–46 kda; sc-137252; 1∶1000; santa cruz biotechnology); c) polyclonal Antibody against Rabbit anti-Human Podocin (h-130; 42 kda; sc-21009; 1∶1000; santa cruz biotechnology); and d) polyclonal Antibody against Rabbit anti-Human Wt1 (c-19; 52 kda; sc-192; 1∶500; santa cruz biotechnology).']	N/A	N/A	[('GO_0016020', 'membrane', 20, 'membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 61, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 87, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 104, 'rabbit'), ('NCBITaxon_9606', 'Homo sapiens', 116, 'human'), ('PR_000004455', 'ATP synthase subunit gamma, mitochondrial', 122, 'AT1 receptor'), ('PR_000029299', 'B-cell CLL/lymphoma 7 protein family member A', 136, 'AT1r'), ('GO_0042571', 'immunoglobulin complex, circulating', 211, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 228, 'mouse'), ('PR_000014368', 'RuvB-like 1', 234, 'renin'), ('PR_000004100', 'AP-2 complex subunit alpha-2', 241, 'A-1'), ('GO_0042571', 'immunoglobulin complex, circulating', 317, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 334, 'rabbit'), ('NCBITaxon_9606', 'Homo sapiens', 346, 'human'), ('PR_000012775', 'polycystic kidney disease 2-like 2 protein', 352, 'podocin'), ('GO_0042571', 'immunoglobulin complex, circulating', 439, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 456, 'rabbit'), ('NCBITaxon_9606', 'Homo sapiens', 468, 'human'), ('PR_000017450', 'protein Wnt-8a', 474, 'WT1')]
PMC3463445	9/2012	S81-PMC3463445	['atp-sensitive potassium channels (katp) are inactivated by an increased atp/adp ratio, which provokes Membrane depolarization and subsequently the activation of voltage-dependent calcium channels [70,71].']	N/A	N/A	[('GO_0016020', 'membrane', 102, 'membrane')]
PMC3483668	10/2012	S138-PMC3483668	['in a nested case-control study, Erythrocyte Membrane N-3 content was higher in Fish Oil supplement users than in nonusers, but Cognitive function did not differ significantly between the groups [67].']	N/A	N/A	[('CL_0000232', 'erythrocyte', 32, 'erythrocyte'), ('GO_0016020', 'membrane', 44, 'membrane'), ('PR_000011459', 'neurotrophin-3', 53, 'n-3'), ('CHEBI_34766', 'Furamizole', 79, 'fish oil'), ('GO_0050890', 'cognition', 127, 'cognitive')]
PMC3577465	2/2013	S80-PMC3577465	['Membranes were incubated with a primary Antibody against Α-Sma and Et-1 overnight at 4°c and with a peroxidase-conjugated secondary Antibody for 60 minutes at room temperature.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 40, 'antibody'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 57, 'α-SMA'), ('PR_000007222', 'protein C-ets-2', 67, 'ET-1'), ('GO_0042571', 'immunoglobulin complex, circulating', 132, 'antibody')]
PMC3608914	3/2013	S105-PMC3608914	['Autophagy is one of the major Cellular Degradation Processes in which parts of the cytoplasm and Intracellular Organelles are engulfed within double-Membraned Vesicles, known as Autophagosomes (klionsky,2007).']	N/A	N/A	[('GO_0006367', 'transcription initiation from RNA polymerase II promoter', 0, 'Autophagy'), ('GO_0000911', 'cytokinesis by cell plate formation', 30, 'cellular degradation processes'), ('GO_0043229', 'intracellular organelle', 97, 'intracellular organelles'), ('GO_0016020', 'membrane', 149, 'membraned'), ('GO_0031982', 'vesicle', 159, 'vesicles'), ('GO_0005776', 'autophagosome', 178, 'autophagosomes')]
PMC3610650	3/2013	S77-PMC3610650	['the supernatant was removed, spun at 41000 rpm for 1 hr at 4°c to obtain the Cytosolic fraction (supernatant) and Membrane fraction (pellet resuspended in 15–30 µl of Lysis buffer).']	N/A	N/A	[('GO_0005829', 'cytosol', 77, 'cytosolic'), ('GO_0016020', 'membrane', 114, 'membrane'), ('GO_0019835', 'cytolysis', 167, 'lysis')]
PMC3610650	3/2013	S107-PMC3610650	['(b) immunoblots of Dmt1, Fpn and Dcytb (Membrane fraction).']	N/A	N/A	[('PR_000006606', 'DNA (cytosine-5)-methyltransferase 1', 19, 'Dmt1'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 25, 'Fpn'), ('PR_000002015', 'MHC class II histocompatibility antigen alpha chain DRA', 33, 'Dcytb'), ('GO_0016020', 'membrane', 40, 'membrane')]
PMC3610650	3/2013	S227-PMC3610650	['(e) representative immunoblots (Membrane fraction) of Dmt1+ire (Nramp21-a, alpha diagnostics), fpn, Dcytb, Hif-2Α (Nuclear fraction) and Ferritin H (Cytosolic fraction).']	N/A	N/A	[('GO_0016020', 'membrane', 32, 'membrane'), ('PR_000006606', 'DNA (cytosine-5)-methyltransferase 1', 54, 'Dmt1'), ('PR_000011409', 'nuclear receptor subfamily 4 group A member 2', 64, 'NRAMP21'), ('PR_000002015', 'MHC class II histocompatibility antigen alpha chain DRA', 100, 'Dcytb'), ('PR_000008594', 'histone H2B type 1-O', 107, 'Hif-2α'), ('GO_0005634', 'nucleus', 115, 'nuclear'), ('CHEBI_69271', 'Inflatin B', 137, 'Ferritin H'), ('PR_000007573', 'formin-like protein 3', 137, 'Ferritin H'), ('GO_0005829', 'cytosol', 149, 'cytosolic')]
PMC3616124	4/2013	S83-PMC3616124	['Membranes were stained for peroxidase activity (supersignal west pico chemiluminescent substrate, fisher scientific, pittsburgh, pa) and imaged (flourochem q system, cell biosciences, santa clara, ca).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes')]
PMC3639110	4/2013	S32-PMC3639110	['foods like Milk, eggs, and meat are good sources of Choline, while most Plants are poorer sources of Choline (a relatively comprehensive list of the foods that contain Choline is available from the united states department of agriculture.47most of the Choline in foods is present in the form of Phosphatidylcholine, a constituent of Membranes.']	N/A	N/A	[('UBERON_0001913', 'milk', 11, 'milk'), ('CHEBI_15354', 'choline', 52, 'choline'), ('NCBITaxon_10088', 'Mus <genus>', 72, 'plants'), ('CHEBI_15354', 'choline', 101, 'choline'), ('CHEBI_15354', 'choline', 168, 'choline'), ('CHEBI_15354', 'choline', 252, 'choline'), ('CHEBI_36710', 'interferon inducer', 295, 'phosphatidylcholine'), ('GO_0016020', 'membrane', 333, 'membranes')]
PMC3675032	6/2013	S61-PMC3675032	['the total protein content on the Membranes were determined as the colour intensity of the ponceau s stain between 37.1–82.2 kda (according to bench mark pre-stained protein ladder from invitrogen).']	N/A	N/A	[('GO_0016020', 'membrane', 33, 'membranes')]
PMC3675032	6/2013	S62-PMC3675032	['after the ponceau s staining, the Membranes were divided at 60 kda to facilitate incubation with multiple Antibodies.']	N/A	N/A	[('GO_0016020', 'membrane', 34, 'membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 106, 'antibodies')]
PMC3675032	6/2013	S63-PMC3675032	['Membranes were blocked in 5% skimmed milk prior to incubation with other Antibodies and subsequently incubated overnight with the Antibodies against Pkcζ (sc-216, santa cruz, ca, usa; see information s3, s5, and s6 for band specificity and quality), Insulin Receptor Beta Subunit ( Insrβ )(sc-711, santa cruz; see information s3, s5, and s6 for band specificity and quality), Phosphoinositide 3 Kinase-P85 Regulatory Subunit ( Pi3K-P85 )(06–195, millipore, billerica, ma, usa; see information s4 for band specificity and quality), and Phosphoinositide 3 Kinase-P110 Catabolic Subunit ( Pi3K-P110 )(sc-602, santa cruz; see information s4 for band specificity and quality), or were incubated with the Antibody against Glut4 (ab37445, abcam, cambridge, uk; see information s3, s5, and s6 for band specificity and quality).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 73, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 130, 'antibodies'), ('PR_000003059', 'protein kinase C beta type', 149, 'PKCζ'), ('PR_000002050', 'interferon regulatory factor 8', 250, 'insulin receptor beta subunit'), ('PR_000009020', "Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase", 282, 'INSRβ'), ('CHEBI_18179', 'phosphoinositide', 376, 'phosphoinositide'), ('PR_000013270', 'pyridoxal phosphate homeostasis protein PLPBP', 376, 'phosphoinositide 3 kinase-'), ('PR_000013030', 'NADPH--cytochrome P450 reductase', 402, 'p85 regulatory subunit'), ('GO_0065007', 'biological regulation', 406, 'regulatory'), ('PR_000012774', 'polycystic kidney disease 2-like 1 protein', 427, 'PI3K-'), ('PR_000001245', 'rhodopsin', 432, 'p85'), ('CHEBI_18179', 'phosphoinositide', 535, 'phosphoinositide'), ('PR_000013270', 'pyridoxal phosphate homeostasis protein PLPBP', 535, 'phosphoinositide 3 kinase-'), ('PR_000004100', 'AP-2 complex subunit alpha-2', 561, 'p110 catabolic subunit'), ('PR_000014702', 'plasminogen activator inhibitor 1', 586, 'PI3K'), ('PR_000000035', 'BMP receptor type-1A', 591, 'p110'), ('GO_0042571', 'immunoglobulin complex, circulating', 699, 'antibody'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 716, 'GLUT4')]
PMC3675032	6/2013	S64-PMC3675032	['subsequently, Membranes were incubated with horseradish peroxidase-conjugated anti-Rabbit Antibodies (#7074, cell signalling technology).']	N/A	N/A	[('GO_0016020', 'membrane', 14, 'membranes'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 83, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 90, 'antibodies')]
PMC3675032	6/2013	S313-PMC3675032	['one of the gels and its associated Membrane are used as an example.']	N/A	N/A	[('GO_0016020', 'membrane', 35, 'membrane')]
PMC3751294	8/2013	S277-PMC3751294	['Dha is synthesized and taken up by Neurons of the developing Brain and hippocampus, which incorporate it into Membrane Phospholipids, especially Phosphatidylethanolamine.']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 0, 'DHA'), ('CL_0000540', 'neuron', 35, 'neurons'), ('UBERON_0000955', 'brain', 61, 'brain'), ('GO_0016020', 'membrane', 110, 'membrane'), ('CHEBI_16247', 'phospholipid', 119, 'phospholipids'), ('CHEBI_16038', 'phosphatidylethanolamine', 145, 'phosphatidylethanolamine')]
PMC3789799	10/2013	S57-PMC3789799	['this mutation occurs within the Membrane proximal region of the Extracellular Domain of the receptor, which is important for ligand binding (figure 3c, upper panel ).']	N/A	N/A	[('GO_0016020', 'membrane', 32, 'membrane'), ('GO_0005576', 'extracellular region', 64, 'extracellular'), ('SO_0000417', 'polypeptide_domain', 78, 'domain')]
PMC3829803	11/2013	S139-PMC3829803	['cells from control wells (no Membrane insert), outer and inner chamber bystander cells were harvested after 48\xa0hours and Irf-1 (a) and Rig-i (b) mrna were measured by qpcr.']	N/A	N/A	[('GO_0016020', 'membrane', 29, 'membrane'), ('PR_000002051', 'interferon regulatory factor 9', 121, 'IRF-1'), ('PR_000014000', 'telomere-associated protein RIF1', 135, 'RIG')]
PMC3829803	11/2013	S280-PMC3829803	['briefly, tw Membranes inserts with 0.02 μm pores served to separate infected cells in the outer chamber from the uninfected bystander cells of the inner chamber.']	N/A	N/A	[('GO_0016020', 'membrane', 12, 'membranes')]
PMC3857567	12/2013	S204-PMC3857567	['Membranes were incubated in primary Antibody overnight at 4°c in heat-sealed bags.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 36, 'antibody')]
PMC3857567	12/2013	S206-PMC3857567	['Membranes were washed and incubated with hrp-conjugated secondary Antibodies (santa cruz, 1:10,000) for 1\u2005hour at room temperature.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 66, 'antibodies')]
PMC3857567	12/2013	S207-PMC3857567	['Membranes were treated with ecl Reagent (bio rad).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('CHEBI_33893', 'reagent', 32, 'reagent')]
PMC3926113	1/2014	S76-PMC3926113	['Membranes were incubated with primary Antibody overnight at 4\xa0°c (1:1000, Cleaved Caspase-3 or 0.5\xa0µg/ml anti-nt or 1:2000 anti-Hne), followed by secondary Antibody(anti-Rabbit Igg-hrp, 7074, cell signaling technology, danvers, ma, usa) 1: 1000, 1:6000 and 1:2000 for anti-Caspase-3, anti-nt and anti-hne proteins respectively.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 38, 'antibody'), ('PR_000005833', 'cleavage and polyadenylation specificity factor subunit 6', 74, 'cleaved caspase-3'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 128, 'HNE'), ('GO_0042571', 'immunoglobulin complex, circulating', 156, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 170, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 177, 'IgG'), ('PR_000002319', 'catenin beta-1 isoform 1', 273, 'caspase-3')]
PMC4034700	5/2014	S65-PMC4034700	['Endoglin is a Membrane Glycoprotein Expressed by Endothelial Cells and Placental Syncytiotrophoblast.']	N/A	N/A	[('PR_000007000', 'eukaryotic translation initiation factor 4 gamma 3', 0, 'Endoglin'), ('GO_0016020', 'membrane', 14, 'membrane'), ('CHEBI_17089', 'glycoprotein', 23, 'glycoprotein'), ('GO_0010467', 'gene expression', 36, 'expressed'), ('CL_0000115', 'endothelial cell', 49, 'endothelial cells'), ('UBERON_0001986', 'endothelium', 49, 'endothelial'), ('UBERON_0003854', 'spinal cord neural plate', 71, 'placental syncytiotrophoblast')]
PMC4037119	5/2014	S292-PMC4037119	['in particular, N-3 Fatty Acids can Modulate Cholesterol-induced reductions in Membrane fluidity by displacing Cholesterol from the Plasma Membrane [124].']	N/A	N/A	[('CHEBI_35418', 'N-acetylneuraminate', 15, 'n-3 fatty acids'), ('GO_0065007', 'biological regulation', 35, 'modulate'), ('CHEBI_16113', 'cholesterol', 44, 'cholesterol'), ('GO_0016020', 'membrane', 78, 'membrane'), ('CHEBI_16113', 'cholesterol', 110, 'cholesterol'), ('GO_0005886', 'plasma membrane', 131, 'plasma membrane')]
PMC4051754	6/2014	S81-PMC4051754	['this was evident particularly for ‘energy metabolism’, ‘Amino Acid Metabolism’, ‘Metabolism Of other Amino Acids’, ‘xenobiotics Biodegradation and Metabolism’, ‘Membrane Transport’ and ‘Circulatory System’.']	N/A	N/A	[('GO_0006739', 'NADP metabolic process', 56, 'Amino Acid Metabolism'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 81, 'Metabolism of ... Amino Acids'), ('CHEBI_37527', 'acid', 107, 'Acids'), ('GO_0042182', 'ketone catabolic process', 128, 'Biodegradation'), ('GO_0008152', 'metabolic process', 147, 'Metabolism'), ('GO_0016020', 'membrane', 161, 'Membrane'), ('GO_0033223', '2-aminoethylphosphonate transport', 161, 'Membrane Transport'), ('UBERON_0001009', 'circulatory system', 186, 'Circulatory System')]
PMC4054662	7/2014	S220-PMC4054662	['Sepp1, which is recruited to the Endothelium in the areas of inflammation, scavenges the powerful Inflammatory Agent Peroxynitrite, thereby reducing oxidative stress and inflammation and shielding Endothelial Membranes from its attack(16,73).']	N/A	N/A	[('PR_000014660', 'septin-8', 0, 'SEPP1'), ('UBERON_0001986', 'endothelium', 33, 'endothelium'), ('CHEBI_60606', 'opioid receptor agonist', 98, 'inflammatory agent'), ('CHEBI_25941', 'peroxynitrite', 117, 'peroxynitrite'), ('UBERON_0001986', 'endothelium', 197, 'endothelial'), ('GO_0016020', 'membrane', 209, 'membranes')]
PMC4089555	5/2014	S62-PMC4089555	['Tsh also upregulates the Expression of Tpo, tg and the Endocytosis of Iodinated tg [11] and increases the translocation of Pendrin to the Apical Membrane of the Thyroid Follicular Cell, thereby enhancing Iodide efflux [33].']	N/A	N/A	[('CHEBI_17855', 'triglyceride', 0, 'TSH'), ('GO_0010467', 'gene expression', 25, 'expression'), ('PR_000016585', 'tripeptidyl-peptidase 1', 39, 'TPO'), ('GO_0006897', 'endocytosis', 55, 'endocytosis'), ('CHEBI_50516', '(24R)-24-hydroxycholesterol', 70, 'iodinated'), ('PR_000015039', 'pendrin', 123, 'pendrin'), ('GO_0045177', 'apical part of cell', 138, 'apical'), ('GO_0016020', 'membrane', 145, 'membrane'), ('CL_0002258', 'thyroid follicular cell', 161, 'thyroid follicular cell'), ('UBERON_0001746', 'capsule of thyroid gland', 161, 'thyroid follicular'), ('CHEBI_16382', 'iodide', 204, 'iodide')]
PMC4090150	7/2014	S156-PMC4090150	['to confirm equal protein loading, the Membranes were re-probed with gapdh/Β-Tubulin Antibodies.']	N/A	N/A	[('GO_0016020', 'membrane', 38, 'membranes'), ('PR_000009991', 'lymphocyte antigen 6 complex locus protein G5c', 74, 'β-tubulin'), ('GO_0042571', 'immunoglobulin complex, circulating', 84, 'antibodies')]
PMC4141279	8/2014	S72-PMC4141279	['Membranes were blocked in 5% non-fat dry milk for 1 h and incubated with primary Antibody for 1 h. Membranes were washed with tbs/0.1% Tween-20 three times and incubated with secondary Antibody for 1 h, then washed with tbs/0.1% Tween-20 three times and reactivity was detected by the enhanced chemiluminescence kit (pierce).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 81, 'antibody'), ('GO_0016020', 'membrane', 99, 'Membranes'), ('CHEBI_53424', 'polysorbate 20', 135, 'Tween-20'), ('GO_0042571', 'immunoglobulin complex, circulating', 185, 'antibody'), ('CHEBI_53424', 'polysorbate 20', 229, 'Tween-20')]
PMC4152245	9/2014	S116-PMC4152245	['Membranes were then washed in tbst for three times.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes')]
PMC4152245	9/2014	S120-PMC4152245	['density data were standardised within Membranes by Expressing the density of each band of interest relative to that of Β-Actin in the same lane.']	N/A	N/A	[('GO_0016020', 'membrane', 38, 'membranes'), ('GO_0010467', 'gene expression', 51, 'expressing'), ('PR_000003676', 'actin, cytoplasmic 1', 119, 'β-actin')]
PMC4152245	9/2014	S231-PMC4152245	['Gpx can modify the Poisonous Peroxide to a non-toxic Hydroxyl Compound in order to protect the Membrane structure and function.']	N/A	N/A	[('PR_000008210', 'glutathione peroxidase 1', 0, 'GPx'), ('CHEBI_26208', 'polyunsaturated fatty acid', 19, 'poisonous peroxide'), ('CHEBI_33598', 'carbocyclic compound', 53, 'hydroxyl compound'), ('GO_0016020', 'membrane', 95, 'membrane')]
PMC4152245	9/2014	S275-PMC4152245	['the Intestinal Epithelial Cells are physically and functionally interconnected via Membrane channels that are composed of the Gap Junction Cx43 Regulating their migration[85].']	N/A	N/A	[('CL_0002486', 'strial intermediate cell', 4, 'intestinal epithelial cells'), ('UBERON_0000160', 'intestine', 4, 'intestinal'), ('UBERON_0000483', 'epithelium', 15, 'epithelial'), ('GO_0016020', 'membrane', 83, 'membrane'), ('GO_0005921', 'gap junction', 126, 'gap junction'), ('PR_000007998', 'gap junction beta-2 protein', 139, 'Cx43'), ('GO_0065007', 'biological regulation', 144, 'regulating')]
PMC4155824	8/2014	S99-PMC4155824	['this Gene encodes a Membrane protein that facilitates the Ligation Of the D-Alanyl carrier Protein with d-alanine [12].']	N/A	N/A	[('SO_0000704', 'gene', 5, 'gene'), ('GO_0016020', 'membrane', 20, 'membrane'), ('GO_0060290', 'transdifferentiation', 58, 'ligation of ... protein'), ('CHEBI_32479', 'D-alpha-glutamyl group', 74, 'D-alanyl')]
PMC4193194	10/2014	S54-PMC4193194	['high levels of this vegf Inhibitor, causes a disruption on vegf by sticking to Endothelial Cell Flt-1 Receptor, found on Membrane.']	N/A	N/A	[('CHEBI_35222', 'inhibitor', 25, 'inhibitor'), ('CL_0000115', 'endothelial cell', 79, 'endothelial cell'), ('UBERON_0001986', 'endothelium', 79, 'endothelial'), ('PR_000001455', 'frizzled-9', 96, 'Flt-1 receptor'), ('GO_0016020', 'membrane', 121, 'membrane')]
PMC4193194	10/2014	S141-PMC4193194	['nadph oxidase is a Membrane-bound Enzyme Complex that catalyzes the one-Electron reduction of Oxygen to O·−2via nadph (babior,2004).']	N/A	N/A	[('GO_0016020', 'membrane', 19, 'membrane'), ('GO_1902494', 'catalytic complex', 34, 'enzyme complex'), ('CHEBI_10545', 'electron', 72, 'electron'), ('CHEBI_33303', 'chalcogen', 94, 'oxygen'), ('CHEBI_86931', 'S b S AcO', 104, 'O·−')]
PMC4210519	10/2014	S85-PMC4210519	['detection of specific proteins was performed after blocking the Membranes for 2 h in 10% fat free Milk/pbst at rt.']	N/A	N/A	[('GO_0016020', 'membrane', 64, 'membranes'), ('UBERON_0001913', 'milk', 98, 'milk')]
PMC4210519	10/2014	S86-PMC4210519	['Membranes were incubated overnight at 4°c with Rat-specific primary Antibodies at the given concentrations: Insrβ, 1:50; Pi3K, 1:200; Pkcζ 1:200; mtor 1:200; Hsl 1:1000; perilipin 1:10000.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 47, 'rat'), ('GO_0042571', 'immunoglobulin complex, circulating', 68, 'antibodies'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 108, 'InsRβ'), ('PR_000014702', 'plasminogen activator inhibitor 1', 121, 'PI3K'), ('PR_000003059', 'protein kinase C beta type', 134, 'PKCζ'), ('PR_000008794', 'heat shock factor protein 5', 158, 'HSL')]
PMC4210519	10/2014	S89-PMC4210519	['equal loading of lanes was checked by staining the Membranes with indian ink.']	N/A	N/A	[('GO_0016020', 'membrane', 51, 'membranes')]
PMC4233040	11/2014	S65-PMC4233040	['Membranes were incubated with a primary Antibody against Et-1 (ab2786, abcam, 1:300 in Antibody diluent) overnight at 4°c and with a peroxidase-conjugated secondary Antibody for 60\xa0min.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 40, 'antibody'), ('PR_000007222', 'protein C-ets-2', 57, 'ET-1'), ('GO_0042571', 'immunoglobulin complex, circulating', 87, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 165, 'antibody')]
PMC4251419	12/2014	S90-PMC4251419	['cathelicidins target gram-positive and negative bacteria, Viruses and Fungi by Membrane disruption, and are Expressed by Neutrophils, Macrophages, Natural Killer Cells, Mast Cells and Epithelial Cells [56,57].']	N/A	N/A	[('NCBITaxon_1', 'root', 58, 'viruses'), ('NCBITaxon_10088', 'Mus <genus>', 70, 'fungi'), ('GO_0016020', 'membrane', 79, 'membrane'), ('GO_0010467', 'gene expression', 108, 'expressed'), ('CL_0000775', 'neutrophil', 121, 'neutrophils'), ('CL_0000235', 'macrophage', 134, 'macrophages'), ('CL_0000623', 'natural killer cell', 147, 'natural killer cells'), ('CL_0000097', 'mast cell', 169, 'mast cells'), ('CL_0000066', 'epithelial cell', 184, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 184, 'epithelial')]
PMC4277121	12/2015	S97-PMC4277121	['additional Hsa21 proteins participate in the Regulation of Nmdar activity and Membrane localization.']	N/A	N/A	[('PR_000008820', 'heat shock protein beta-8', 11, 'Hsa21'), ('GO_0065007', 'biological regulation', 45, 'regulation'), ('GO_0005643', 'nuclear pore', 59, 'NMDAR'), ('GO_0016020', 'membrane', 78, 'membrane')]
PMC4277121	12/2015	S98-PMC4277121	['the guanine Nucleotide Exchange Factor (Tiam1), the multidomain Endocytic protein (Itsn1), and App interact with nmdar and the Phosphoinositol phosphatase (Synj1) tethers Tiam1 at the Membrane to facilitate its interaction with Nmdar.']	N/A	N/A	[('PR_000011040', 'nuclear receptor coactivator 1', 12, 'nucleotide exchange factor'), ('PR_000016339', 'T-cell immunoglobulin and mucin domain-containing protein 4', 40, 'TIAM1'), ('GO_0006897', 'endocytosis', 64, 'endocytic'), ('PR_000009116', 'insulin gene enhancer protein ISL-1', 83, 'ITSN1'), ('PR_000004168', 'amyloid-beta precursor protein', 95, 'APP'), ('CHEBI_26125', 'phytosterols', 127, 'phosphoinositol'), ('PR_000015890', 'synaptophysin', 156, 'SYNJ1'), ('PR_000016339', 'T-cell immunoglobulin and mucin domain-containing protein 4', 171, 'TIAM1'), ('GO_0016020', 'membrane', 184, 'membrane'), ('GO_0005643', 'nuclear pore', 228, 'NMDAR')]
PMC4277409	12/2014	S62-PMC4277409	['Membranes were viewed and analysed using the chemi-doc system (bio-rad laboratories; gladesville, nsw, australia).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes')]
PMC4280220	12/2014	S178-PMC4280220	['imprinted paternal Alleles Regulate Formation Of Placenta and Membranes surrounding the Embryo, whereas the Development Of the Embryo itself requires contribution from the maternally derived Alleles[5],[86].']	N/A	N/A	[('SO_0001023', 'allele', 19, 'alleles'), ('GO_0065007', 'biological regulation', 27, 'regulate'), ('GO_0090009', 'primitive streak formation', 36, 'formation of placenta'), ('UBERON_0001987', 'placenta', 49, 'placenta'), ('GO_0016020', 'membrane', 62, 'membranes'), ('GO_0007601', 'visual perception', 88, 'embryo'), ('UBERON_0000922', 'embryo', 88, 'embryo'), ('GO_0009790', 'embryo development', 108, 'development of ... embryo'), ('UBERON_0000922', 'embryo', 127, 'embryo'), ('SO_0001023', 'allele', 191, 'alleles')]
PMC4303849	1/2015	S173-PMC4303849	['its mechanism of action includes bacterial Membrane Disruption and activation of toll-like receptors and Macrophage and Neutrophil Chemotaxis [156].']	N/A	N/A	[('GO_0016020', 'membrane', 43, 'membrane'), ('GO_0042740', 'exogenous antibiotic catabolic process', 52, 'disruption'), ('CL_0000235', 'macrophage', 105, 'macrophage'), ('CL_0000775', 'neutrophil', 120, 'neutrophil'), ('GO_0007567', 'parturition', 120, 'neutrophil'), ('GO_0006935', 'chemotaxis', 131, 'chemotaxis')]
PMC4354412	3/2015	S239-PMC4354412	['when Mammary Cells are destroyed or Membrane-bound globules break down, the cd14+Membrane fragments can be shed into the Milk.']	N/A	N/A	[('CL_0002325', 'mammary alveolar cell', 5, 'mammary cells'), ('UBERON_0002391', 'lymph', 5, 'mammary'), ('GO_0016020', 'membrane', 36, 'membrane'), ('GO_0016020', 'membrane', 81, 'membrane'), ('UBERON_0001913', 'milk', 121, 'milk')]
PMC4358872	2/2015	S77-PMC4358872	['Postnatal exposure to gh acts on Membrane Lipids to program response to cellular perturbations.']	N/A	N/A	[('GO_0007567', 'parturition', 0, 'Postnatal'), ('GO_0016020', 'membrane', 33, 'membrane'), ('CHEBI_18059', 'lipid', 42, 'lipids')]
PMC4358872	2/2015	S78-PMC4358872	['elevated gh in rodents creates a more unsaturated Lipid profile in Cell Membranes by activating Membrane desaturase pathways [57].']	N/A	N/A	[('CHEBI_18059', 'lipid', 50, 'lipid'), ('GO_0005886', 'plasma membrane', 67, 'cell membranes'), ('GO_0016020', 'membrane', 96, 'membrane')]
PMC4360220	2/2015	S100-PMC4360220	['the highly significant go categories were Membrane, development, signal transduction, and Cognition associated (figure 2b).']	N/A	N/A	[('GO_0016020', 'membrane', 42, 'membrane'), ('GO_0050890', 'cognition', 90, 'cognition')]
PMC4363193	3/2015	S212-PMC4363193	['Cd36 codes for a Membrane Glycoprotein which binds Long Chain Fatty Acids for Transport Into Cells [38].']	N/A	N/A	[('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 0, 'CD36'), ('GO_0016020', 'membrane', 17, 'membrane'), ('CHEBI_17089', 'glycoprotein', 26, 'glycoprotein'), ('CHEBI_25002', 'lactosamines', 51, 'long chain fatty acids'), ('GO_0046907', 'intracellular transport', 78, 'transport into cells')]
PMC4372177	2/2015	S188-PMC4372177	['the molecular cascade of Hh Signaling involves the initial binding of one of the hh proteins Sonic Hh ( Shh ), Indian Hh ( ihh ), and Desert Hh ( dhh ), with receptor pach1 and pach2 that release its inhibition on the Membrane receptor Smoothened ( Smo ).']	N/A	N/A	[('GO_0060078', 'regulation of postsynaptic membrane potential', 25, 'Hh signaling'), ('PR_000015308', 'zinc finger protein SNAI1', 93, 'Sonic Hh'), ('PR_000014841', 'sonic hedgehog protein', 104, 'SHH'), ('PR_000009167', 'involucrin', 111, 'Indian Hh'), ('PR_000006450', 'diacylglycerol kinase theta', 134, 'Desert Hh'), ('GO_0016020', 'membrane', 218, 'membrane'), ('PR_000015293', 'sphingomyelin phosphodiesterase 2', 236, 'Smoothened'), ('PR_000015279', 'mitochondrial dynamics protein MID51', 249, 'SMO')]
PMC4377870	3/2015	S68-PMC4377870	['Α-Tocopherol is a form of Vitamin E, which helps maintain integrity of Membrane Fatty Acids, by inhibiting Lipid peroxidation [22].']	N/A	N/A	[('CHEBI_27725', 'butin', 0, 'α-tocopherol'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin E'), ('GO_0016020', 'membrane', 71, 'membrane'), ('CHEBI_35366', 'fatty acid', 80, 'fatty acids'), ('CHEBI_18059', 'lipid', 107, 'lipid')]
PMC4386645	3/2015	S58-PMC4386645	['moreover, ultrastructural changes on a cellular level, such as appearance of Membrane-bound Autophagic Vacuoles, Pyknotic Nuclei, and dilated Nuclear Periphery can be observed in zinc deficient Rats [31].']	N/A	N/A	[('GO_0016020', 'membrane', 77, 'membrane'), ('GO_0005776', 'autophagosome', 92, 'autophagic vacuoles'), ('GO_0006915', 'apoptotic process', 92, 'autophagic'), ('GO_0030263', 'apoptotic chromosome condensation', 113, 'pyknotic'), ('GO_0005634', 'nucleus', 122, 'nuclei'), ('GO_0034399', 'nuclear periphery', 142, 'nuclear periphery'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 194, 'rats')]
PMC4386645	3/2015	S174-PMC4386645	['Matrix metalloproteinases (Mmps) are a family of zinc binding Extracellular Matrix degrading enzymes.']	N/A	N/A	[('GO_0031430', 'M band', 0, 'Matrix'), ('GO_0016020', 'membrane', 27, 'MMPs'), ('GO_0031012', 'extracellular matrix', 62, 'extracellular matrix')]
PMC4388824	4/2015	S76-PMC4388824	['Membranes were viewed and analysed using the chemidoc xrs system (bio-rad laboratories).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes')]
PMC4392553	3/2015	S180-PMC4392553	['[305] while Mn2+is the form of Mn that catalyzes enzyme reactions, Mn3+, similar to Al3+, is directly toxic to Neuronal Membranes.']	N/A	N/A	[('CHEBI_29108', 'calcium(2+)', 12, 'Mn2+'), ('CHEBI_25614', 'nylons', 31, 'Mn'), ('CHEBI_82138', 'Lythidathion', 67, 'Mn3+,'), ('CHEBI_28748', 'doxorubicin', 84, 'Al3+,'), ('CL_0000540', 'neuron', 111, 'neuronal'), ('GO_0016020', 'membrane', 120, 'membranes')]
PMC4425955	4/2015	S86-PMC4425955	['the incubation of the Membrane with Antibody neutralized by blocking peptide resulted in absence of band corresponding to the Agtr2 receptor.']	N/A	N/A	[('GO_0016020', 'membrane', 22, 'membrane'), ('GO_0042571', 'immunoglobulin complex, circulating', 36, 'antibody'), ('PR_000001180', 'opsin-5', 126, 'AGTR2')]
PMC4483650	6/2015	S261-PMC4483650	['Membranes were blocked in 5% (w/v) nonfat milk in Tris-buffered saline containing 0.05% (v/v) Tween (tbst) for 2 h, then incubated first with primary Antibodies (1:1000 dilution) followed by redetection with secondary Antibodies (1:1000 dilution) in tbst-5% (w/v) Milk overnight at 4 °c.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('CHEBI_9754', 'tris', 50, 'Tris'), ('CHEBI_53422', 'polysorbate', 94, 'Tween'), ('GO_0042571', 'immunoglobulin complex, circulating', 150, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 218, 'antibodies'), ('UBERON_0001913', 'milk', 264, 'milk')]
PMC4516488	9/2009	S55-PMC4516488	['Membranes were blocked for 1 hr with 5% non-fat dry milk in tbs containing 0.05% Tween-20 incubated with primary Antibodies (directed against: total Akt, pakt (s473), total pea-15, ppea-15 (s116) and Β-Actin as indicated in the figures) and visualized by chemiluminescence [28].']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('CHEBI_53424', 'polysorbate 20', 81, 'Tween-20'), ('GO_0042571', 'immunoglobulin complex, circulating', 113, 'antibodies'), ('PR_000003888', 'A-kinase anchor protein 14', 149, 'AKT'), ('PR_000003676', 'actin, cytoplasmic 1', 200, 'β-actin')]
PMC4516488	9/2009	S119-PMC4516488	['Membranes were probed with Antibodies identical to those used on the protein array (kinexus), visualized with the ecl detection system and quantified by using iris identification software (fig.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 27, 'antibodies')]
PMC4547703	8/2015	S24-PMC4547703	['the Abca1 Gene, a member of the atp-binding Cassette a (Abca1) transporter superfamily, encodes a Membrane protein that facilitates the cellular efflux of Cholesterol and Phospholipids.']	N/A	N/A	[('PR_000003555', 'ATP-binding cassette sub-family C member 10', 4, 'ABCA1'), ('SO_0000704', 'gene', 10, 'gene'), ('SO_0005853', 'gene_cassette', 44, 'cassette'), ('PR_000003555', 'ATP-binding cassette sub-family C member 10', 56, 'ABCA1'), ('GO_0016020', 'membrane', 98, 'membrane'), ('CHEBI_16113', 'cholesterol', 155, 'cholesterol'), ('CHEBI_16247', 'phospholipid', 171, 'phospholipids')]
PMC4642531	8/2015	S60-PMC4642531	['at Membrane potentials higher than −50\u2009mv, stocs were observed in both the control and Caffeine group.']	N/A	N/A	[('GO_0016020', 'membrane', 3, 'membrane'), ('CHEBI_27732', 'caffeine', 87, 'caffeine')]
PMC4682815	12/2015	S83-PMC4682815	['all mrna levels are presented relative to the geometric mean of the three control Genes, Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide ( ywhaz ), ubiquitin c ( ubc ) and topoisomerase ( Top1 ) [27].10.1371/journal.pone.0143653.t001\n\ncaption (table-Wrap): table 1\ninformation on amino acid transporter Genes, Primers and probes.amino acid transportergenegene idgenebank accession no.Primersroche universal probe library no.lat1slc7a58140nm_003486.5f-5′-gtggaaaaacaagcccaagt-3’r-5′-gcatgagcttctgacacagg-3’25lat2slc7a823428nm_182728.1nm_012244.2f-5′-ttgccaatgtcgcttatgtc-3’r-5′-ggagcttctctccaaaagtcac-3’17asct1slc1a46509nm_003038.2f-5′-tttgcgacagcatttgctac-3’r-5′-gcacttcatcatagagggaagg-3’78asct2slc1a56510nm_005628.2nm_001145145.1f-5′-gaggaatatcaccggaacca-3’r-5′-aggatgttcatcccctcca-3’43y+lat1slc7a79056nm_001126106.1nm_003982.3f-5′-acactgccgtgagaacctg-3’r-5′-aggagaggaaacccttcacc-3’72y+lat2slc7a69057nm_001076785.1nm_003983.4f-5′-gctgtgatcccccatacct-3’r-5′-ggcacagttcacaaatgtcag-3’664f2hcslc3a26520nm_001012661.1f-5′-tggttctccactcaggttga-3’r-5′-cagccaaaactccagagcat-3’49eaat1slc1a36507nm_004172.4f-5′-ttgaactgaacttcggacaaatta-3’r-5′-attccagctgccccaatact-3’76eaat2slc1a26506nm_004171.3f-5′-aaaatgctcattctccctctaatc-3’r-5′-gccactagccttagcatcca-3’78eaat3slc1a16505nm_004170.4f-5′-agttgaatgacctggacttgg-3’r-5′-gcagatgtggccgtgatac-3’9eaat4slc1a66511nm_005071.1f-5′-tgcagatgctggtgttacct-3’r-5′-gttgtccagggatgccata-3’19eaat5slc1a76512nm_006671.4f-5′-cgcccaggtcaacaactac-3’r-5′-gctgcagtggctgtgatact-5’9snat1slc38a181539nm_030674.3nm_001077484.1f-5′-attttgggactcgcctttg-3’r-5′-agcaatgtcactgaagtcaaaagt-3’47snat2slc38a254407nm_018976.3f-5′-cctatgaaatctgtacaaaagattgg-3’F-5′-ttgtgtacccaatccaaaacaa-3’9snat4slc38a455089nm_018018.4nm_001143824.1f-5′-tgttctggtcatccttgtgc-3’r-5′-aaaactgctggaagaataaaaatcag-3’29tat1slc16a10117247nm_018593.4f-5′-ggtgtgaagaaggtttatctacagg-3′R-5′-agggccccaaagatgcta-3′6lat3slc43a18501nm_003627.5nm_001198810.1f-5′-gccctcatgattggctctta-3’r-5′-ccggcatcgtagatcagc-3’29lat4slc42a2124935nm_001284498.1nm_152346.2f-5′-acaagtatggcccgaggaa-3’r-5′-gcaatcagcaagcaggaaa-3’3\nslc, solute carrier; F, Forward; R, Reverse; 4f2hc, type-ii Membrane Glycoprotein heavy chain.10.1371/journal.pone.0143653.t002\n\ncaption (table-wrap): table 2\ninformation on Metabolic Genes, Primers and probes.Metabolic Genesgene idgenebank accession no.Primersroche universal probe library no.branched chain aminotransferase 1mitochondrial (bcatm) 587nm_001190.2f-5′-aaaatgggcctgagctgat-3’r-5′-gtgggctctgattccgtact-3’17branched chain aminotransferase 2cytosolic (bcatc) 586nm_005504.5f-5′-gatgtttggctctggtacagc-3’r-5′-ggaccattctccatagttggaa-3’61glutaminase (gls1) Kidney Isoform2744Nm_014905.3f-5′-tgcagagggtcatgttgaag-3’f-5′-catccatgggagtgttattcc-3’11glutamine synthetase (glul) 2752nm_002065.4nm_001033044.1nm_001033056.1f-5′-ccataccaacttcagcacca-3’r-5′-caatggcctcctcgatgta-3’52glutamate dehydrogenase (glud) mitochondrial2746nm_005271.2nm_012084.3f-5′-cactctggcttggcatacac-3’r-5′-tcaggtccaatcccaggtta-3’76alanine Aminotransferase 1 (Gpt1) 2875nm_005309.2f-5′-catagtgcagcgagccttg-3’r-5′-ggatgacctcggtgaaagg-3’15Alanine Aminotransferase 2 (Gpt2) 84706nm_133443.1f-5′-ggatcttcattcctgccaaa-3’r-5′-acatgtctggagccatttga-3’75aspartate Aminotransferase 1 (Got1 ) Cytosolic2805Nm_002079.1f-5′-caactgggattgacccaact-3’r-5′-ggaacagaaaccggtgctt-3’38aspartate Aminotransferase 2 (Got2) mitochondrial2806nm_002080.2f-5′-ccattctgaacaccccagat-3’r-5′-ggtcagccatgactttcactt-3’46\nf, Forward; r, Reverse\n\nprobe and Primer design\noligonucleotide probes and Primers were designed using the roche probefinder version 2.45 for Human.']	N/A	N/A	[('SO_0000704', 'gene', 82, 'genes'), ('PR_000028799', 'tubulin', 89, 'tyrosine'), ('PR_000016523', 'tensin-4', 229, 'TOP1'), ('PR_000017453', 'protein Wnt-9b', 291, 'WRAP'), ('SO_0000704', 'gene', 344, 'genes'), ('SO_0000112', 'primer', 351, 'primers'), ('SO_0000112', 'primer', 425, 'PrimersRoche'), ('SO_0001030', 'forward', 1701, 'F'), ('SO_0001031', 'reverse', 1900, 'R'), ('SO_0001030', 'forward', 2142, 'F'), ('SO_0001030', 'forward', 2145, 'forward'), ('SO_0001031', 'reverse', 2154, 'R'), ('SO_0001031', 'reverse', 2157, 'reverse'), ('GO_0016020', 'membrane', 2181, 'membrane'), ('CHEBI_17089', 'glycoprotein', 2190, 'glycoprotein'), ('GO_0008152', 'metabolic process', 2295, 'metabolic'), ('SO_0000704', 'gene', 2305, 'genes'), ('SO_0000112', 'primer', 2312, 'primers'), ('GO_0008152', 'metabolic process', 2331, 'Metabolic'), ('SO_0000704', 'gene', 2341, 'GenesGene'), ('SO_0000112', 'primer', 2375, 'PrimersRoche'), ('UBERON_0002113', 'kidney', 2686, 'kidney'), ('SO_0000810', 'chimeric_cDNA_clone', 2693, 'isoform2744NM_014905'), ('PR_000003611', 'acetyl-CoA acetyltransferase, cytosolic', 3038, 'aminotransferase 1'), ('PR_000008160', 'glycerol-3-phosphate acyltransferase 2, mitochondrial', 3058, 'GPT1'), ('CHEBI_64808', 'tetrahydro-4-hydroxyphenylpyruvic acid', 3133, '15Alanine'), ('PR_000003611', 'acetyl-CoA acetyltransferase, cytosolic', 3143, 'aminotransferase 2'), ('PR_000008190', 'adhesion G-protein coupled receptor G2', 3163, 'GPT2'), ('PR_000003611', 'acetyl-CoA acetyltransferase, cytosolic', 3253, 'aminotransferase 1'), ('PR_000008166', 'glypican-4', 3273, 'GOT1'), ('GO_0005835', 'fatty acid synthase complex', 3280, 'cytosolic2805NM_002079'), ('PR_000003611', 'acetyl-CoA acetyltransferase, cytosolic', 3371, 'aminotransferase 2'), ('PR_000008160', 'glycerol-3-phosphate acyltransferase 2, mitochondrial', 3391, 'GOT2'), ('SO_0001030', 'forward', 3488, 'forward'), ('SO_0001031', 'reverse', 3500, 'reverse'), ('SO_0000112', 'primer', 3519, 'primer'), ('SO_0000112', 'primer', 3560, 'primers'), ('NCBITaxon_9606', 'Homo sapiens', 3627, 'human')]
PMC4701936	1/2016	S30-PMC4701936	['Endocannabinoids are signaling Lipids produced from Membrane long-chain fatty acids in response to Neuronal activity (mackie,2008).']	N/A	N/A	[('CHEBI_4853', 'esculin', 0, 'Endocannabinoids'), ('CHEBI_18059', 'lipid', 31, 'lipids'), ('GO_0016020', 'membrane', 52, 'membrane'), ('CL_0000540', 'neuron', 99, 'neuronal')]
PMC4703052	1/2016	S45-PMC4703052	['innate Immune defenses provide resistance to disease without recognizing specific Antigens, and include Anatomical barriers such as skin and Mucosal Membranes, anti-Microbial soluble proteins (e.g.']	N/A	N/A	[('GO_0007566', 'embryo implantation', 7, 'immune'), ('UBERON_0002405', 'immune system', 7, 'immune'), ('CHEBI_59132', 'antigen', 82, 'antigens'), ('UBERON_0001062', 'anatomical entity', 104, 'anatomical'), ('UBERON_0000344', 'mucosa', 141, 'mucosal'), ('GO_0016020', 'membrane', 149, 'membranes'), ('NCBITaxon_10088', 'Mus <genus>', 165, 'microbial')]
PMC4738402	11/2015	S40-PMC4738402	['biochemical determinations\npreparation of homogenates and Membranes, measurement of total muscarinic receptors and enzyme activities, and muscarinic receptor‐mediated Activation Of G‐Proteins were carried out as described previously (machova et\xa0al .2008).']	N/A	N/A	[('GO_0016020', 'membrane', 58, 'membranes'), ('GO_0006915', 'apoptotic process', 167, 'activation of G‐proteins')]
PMC4738402	11/2015	S43-PMC4738402	['G‐Protein Activation was determined as the increase in Carbachol‐activated (0.3–100\xa0μm) guanosine 5′‐(Γ35‐Thio)‐triphosphate (gtp‐Γ35S; 500 pm, arc) binding to Membranes (5–15\xa0μg protein).']	N/A	N/A	[('GO_0045023', 'G0 to G1 transition', 0, 'G‐protein activation'), ('CHEBI_3385', 'carbachol', 55, 'carbachol'), ('CHEBI_79358', 'ibha#26', 99, '′‐(γ35'), ('CHEBI_29917', 'thiol group', 106, 'thio'), ('CHEBI_76380', 'I11', 130, 'γ35S'), ('GO_0016020', 'membrane', 160, 'membranes')]
PMC4789467	3/2016	S100-PMC4789467	['amino acids are actively transported against their concentration gradient, using both Membrane transporter proteins and the input of additional energy.']	N/A	N/A	[('GO_0016020', 'membrane', 86, 'membrane')]
PMC4825102	2/2016	S100-PMC4825102	['ampk is an Energy-Sensing enzyme recognised as a master regulator of whole-body energy homoeostasis; its activation increases Glut4 Expression and Membrane Translocation in Skeletal muscle, thereby improving Glucose Uptake(93).']	N/A	N/A	[('GO_0090505', 'epiboly involved in wound healing', 11, 'energy-sensing'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 126, 'GLUT4'), ('GO_0010467', 'gene expression', 132, 'expression'), ('GO_0016020', 'membrane', 147, 'membrane'), ('GO_0055086', 'nucleobase-containing small molecule metabolic process', 147, 'membrane translocation'), ('UBERON_0004288', 'skeleton', 173, 'skeletal'), ('CHEBI_17234', 'glucose', 208, 'glucose'), ('GO_0046323', 'glucose import', 208, 'glucose uptake')]
PMC4835505	4/2016	S82-PMC4835505	['Membranes were visualized with the use of the odyssey infrared imaging system (li-cor) and densitometry analysis carried out with the carestream software (napoli et al.,2013).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes')]
PMC4873529	3/2016	S44-PMC4873529	['the Membranes were incubated in blocking buffer followed by overnight incubation with primary Antibodies at 4\xa0°c (table1); the Membranes were then incubated with the secondary Antibodies (table1).']	N/A	N/A	[('GO_0016020', 'membrane', 4, 'membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 94, 'antibodies'), ('GO_0016020', 'membrane', 127, 'membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 176, 'antibodies')]
PMC4896250	4/2016	S4608-PMC4896250	['methods: female balb/c and cba/j Mice were used between 8 to 16 weeks of age, plasma Membranes were prepared from Cd40 mrna Transfected to baculovirus sf-9 cells.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 33, 'mice'), ('GO_0016020', 'membrane', 85, 'membranes'), ('PR_000001309', 'CD70 molecule', 114, 'CD40'), ('GO_0009294', 'DNA mediated transformation', 124, 'transfected')]
PMC4896250	4/2016	S8382-PMC4896250	['methods\nthree different Mice strains were employed: wt balb/c Mice, kn1 Mice displaying 4- to 6- fold elevated mean Serum Ige levels (1), and dm1m2 transgenic Mice that lack the Transmembrane and Cytoplasmic Domains of Membrane-bound Ige resulting in reduced Serum Ige levels down to 5% of wt Mice (2).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 24, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 62, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 72, 'mice'), ('UBERON_0001977', 'blood serum', 116, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 122, 'IgE'), ('NCBITaxon_10088', 'Mus <genus>', 159, 'mice'), ('GO_0042651', 'thylakoid membrane', 178, 'transmembrane'), ('GO_0005737', 'cytoplasm', 196, 'cytoplasmic'), ('SO_0000417', 'polypeptide_domain', 208, 'domains'), ('GO_0016020', 'membrane', 219, 'membrane'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 234, 'IgE'), ('UBERON_0001977', 'blood serum', 259, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 265, 'IgE'), ('NCBITaxon_10088', 'Mus <genus>', 293, 'mice')]
PMC4910734	6/2015	S6-PMC4910734	['Aldehydes also react with selective Cytosolic and Membrane proteins in the cell of origin; then some types migrate to damage neighboring cells.']	N/A	N/A	[('CHEBI_17478', 'aldehyde', 0, 'Aldehydes'), ('GO_0005829', 'cytosol', 36, 'cytosolic'), ('GO_0016020', 'membrane', 50, 'membrane')]
PMC4915063	6/2016	S128-PMC4915063	['as many as 70 Genes, or 41\xa0% of our list, were annotated as “intrinsic to Membrane” (corrected p \u2009=\u20090.011).']	N/A	N/A	[('SO_0000704', 'gene', 14, 'genes'), ('GO_0016020', 'membrane', 74, 'membrane')]
PMC4915063	6/2016	S132-PMC4915063	['the enriched functional groups such as “intrinsic to Membrane,” “Anatomical Structure Development” and “Nervous System Development” also included most of the Genes from the Wnt and Cadherin Pathways.']	N/A	N/A	[('GO_0016020', 'membrane', 53, 'membrane'), ('GO_0060928', 'atrioventricular node cell development', 65, 'anatomical structure development'), ('UBERON_0001062', 'anatomical entity', 65, 'anatomical'), ('GO_0007399', 'nervous system development', 104, 'nervous system development'), ('UBERON_0001016', 'nervous system', 104, 'nervous system'), ('SO_0000704', 'gene', 158, 'genes'), ('GO_0016055', 'Wnt signaling pathway', 173, 'Wnt ... pathways'), ('PR_000005009', 'calpain-1 catalytic subunit', 181, 'cadherin')]
PMC4919621	6/2016	S187-PMC4919621	['Membranes were incubated with the specific primary Antibodies (for Antibody specifications and dilutions seetable s10) at 4\u2009°c overnight.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 51, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibody')]
PMC4989298	8/2016	S253-PMC4989298	['Arachidonic Acid it is the predominant precursor, present in high concentrations in all Membrane Phospholipids.']	N/A	N/A	[('CHEBI_15843', 'arachidonic acid', 0, 'Arachidonic acid'), ('GO_0016020', 'membrane', 88, 'membrane'), ('CHEBI_16247', 'phospholipid', 97, 'phospholipids')]
PMC4995781	8/2016	S104-PMC4995781	['1\n\nMembrane Lipid composition\nthe Fatty Acid compositions of red Quadriceps and Soleus Skeletal Muscles and Liver were profiled.']	N/A	N/A	[('GO_0016020', 'membrane', 3, 'Membrane'), ('CHEBI_18059', 'lipid', 12, 'lipid'), ('CHEBI_35366', 'fatty acid', 34, 'fatty acid'), ('UBERON_0001377', 'quadriceps femoris', 65, 'quadriceps'), ('UBERON_0001134', 'skeletal muscle tissue', 80, 'soleus skeletal muscles'), ('UBERON_0002107', 'liver', 108, 'liver')]
PMC4999868	8/2016	S65-PMC4999868	['the pelleted crude Membrane fraction was resuspended and 12\u2009mm Mgcl2Was added.']	N/A	N/A	[('GO_0016020', 'membrane', 19, 'membrane'), ('CHEBI_6636', 'magnesium dichloride', 63, 'MgCl2was')]
PMC4999868	8/2016	S135-PMC4999868	['Membrane Trafficking of specific system A (Snat 2) and system l (Lat1) amino acid transporter Isoforms in Primary Human Trophoblast Cells is Regulated by Nedd4-2 dependent ubiquitination35.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membrane'), ('GO_0055085', 'transmembrane transport', 0, 'Membrane trafficking'), ('PR_000004370', 'asialoglycoprotein receptor 2', 40, 'A'), ('PR_000015209', 'sodium/calcium exchanger 3', 43, 'SNAT 2'), ('PR_000015059', 'solute carrier family 2, facilitated glucose transporter member 10', 65, 'LAT1'), ('SO_0001060', 'sequence_variant', 94, 'isoforms'), ('CL_0000001', 'primary cultured cell', 106, 'primary ...'), ('NCBITaxon_9606', 'Homo sapiens', 114, 'human'), ('CL_0000351', 'trophoblast cell', 120, 'trophoblast cells'), ('UBERON_0000088', 'trophoblast', 120, 'trophoblast'), ('GO_0065007', 'biological regulation', 141, 'regulated'), ('PR_000011164', 'nuclear factor of activated T-cells, cytoplasmic 2', 154, 'Nedd4')]
PMC5025983	8/2015	S33-PMC5025983	['Docosahexaenoic Acid (Dha), which is found in the Brain and Retinal Membranes, Regulates Membrane permeability, and improves receptor differentiation.']	N/A	N/A	[('CHEBI_78869', 'octacosapentaenoic acid', 0, 'Docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 22, 'DHA'), ('UBERON_0000955', 'brain', 50, 'brain'), ('UBERON_0000966', 'retina', 60, 'retinal'), ('GO_0016020', 'membrane', 68, 'membranes'), ('GO_0065007', 'biological regulation', 79, 'regulates'), ('GO_0016020', 'membrane', 89, 'membrane')]
PMC5025983	8/2015	S59-PMC5025983	['imbalances in Fatty Acid Intake during fetal development alter Fatty Acid levels in Membrane Phospholipids and stored Triglycerides, therefore disrupt the cellular environment and cause structural and functional programming [5].']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 14, 'fatty acid'), ('GO_0033565', 'ESCRT-0 complex', 14, 'fatty acid intake'), ('CHEBI_35366', 'fatty acid', 63, 'fatty acid'), ('GO_0016020', 'membrane', 84, 'membrane'), ('CHEBI_16247', 'phospholipid', 93, 'phospholipids'), ('CHEBI_17855', 'triglyceride', 118, 'triglycerides')]
PMC5028238	10/2016	S62-PMC5028238	['the proportion of Dhcr7 mutations that exist in a trans-Membrane Domain are shown infigure 2b.']	N/A	N/A	[('PR_000006474', 'ATP-dependent RNA helicase A', 18, 'DHCR7'), ('GO_0016020', 'membrane', 56, 'membrane'), ('SO_0000417', 'polypeptide_domain', 65, 'domain')]
PMC5096291	11/2016	S73-PMC5096291	['the bottom and top of the box represent the 25th and 75th percentile of Dna Methylation within the group, respectively, and the middle band the median Dna Methylation value\nthe dmrs identified at Birth were located in Genes with a variety of functions, including Lipid Exchange Between Membranes ( Esyt3 [32]), Plasma Membrane function ( Slc12A6 [33]), Appetite Regulation ( cck [34]), Immune function ( Raet1L and Ltb [35,36]) and Neurodevelopment/Brain function ( Slc12A6 , Trak1 , Lphn3 and Rfpl2 [33,37,38]).']	N/A	N/A	[('GO_0006306', 'DNA methylation', 72, 'DNA methylation'), ('GO_0006306', 'DNA methylation', 151, 'DNA methylation'), ('GO_0007567', 'parturition', 196, 'birth'), ('SO_0000704', 'gene', 218, 'genes'), ('CHEBI_18059', 'lipid', 263, 'lipid'), ('GO_0050902', 'leukocyte adhesive activation', 263, 'lipid exchange between membranes'), ('GO_0016020', 'membrane', 286, 'membranes'), ('PR_000007270', 'exostosin-like 1', 298, 'ESYT3'), ('GO_0005886', 'plasma membrane', 311, 'plasma membrane'), ('PR_000014939', 'urea transporter 2', 338, 'SLC12A6'), ('GO_0034205', 'amyloid-beta formation', 353, 'appetite regulation'), ('UBERON_0002405', 'immune system', 386, 'immune'), ('PR_000013796', 'RNA-binding protein 38', 404, 'RAET1L'), ('PR_000009881', 'peroxisomal Lon protease 2', 415, 'LTB'), ('GO_0007399', 'nervous system development', 432, 'neurodevelopment'), ('UBERON_0000955', 'brain', 449, 'brain'), ('PR_000014939', 'urea transporter 2', 466, 'SLC12A6'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 476, 'TRAK1'), ('PR_000009880', 'Lon protease, mitochondrial', 484, 'LPHN3'), ('PR_000013939', 'Ral-GDS-related protein', 494, 'RFPL2')]
PMC5292192	1/2017	S103-PMC5292192	['this enzyme prefers species of Ptdetn that contain Long-Chain polyunsaturated Fatty Acids such as Dha [47], thereby forming Dha-enriched species of Ptdcho in Membranes especially in the Brain.']	N/A	N/A	[('PR_000012582', 'ATP-dependent 6-phosphofructokinase, liver type', 31, 'PtdEtn'), ('CHEBI_28911', 'cob(III)alamin', 51, 'long-chain'), ('CHEBI_35366', 'fatty acid', 78, 'fatty acids'), ('CHEBI_17874', 'dihydrozeatin', 98, 'DHA'), ('CHEBI_17874', 'dihydrozeatin', 124, 'DHA'), ('PR_000012582', 'ATP-dependent 6-phosphofructokinase, liver type', 148, 'PtdCho'), ('GO_0016020', 'membrane', 158, 'membranes'), ('UBERON_0000955', 'brain', 186, 'brain')]
PMC5303734	2/2017	S44-PMC5303734	['Membranes were then incubated in secondary Antibodies (goat anti-Rabbit or Rabbit anti-Mouse Igg horseradish peroxidase-conjugated secondary Antibodies, 1:5000 for opa-1, mnsod, Tom-20, oxphos Complexes; 1:2000 for Drp-1, Pink-1, Lc3A/b; 1:500 for Parkin; santa cruz biotechnology, dallas, tx, usa) for 1 h. protein Expression was detected by supersignal west pico chemiluminescent substrate (thermo, waltham, ma, usa) and fujifilm las-3000 (fujifilm, tokyo, japan).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 43, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 65, 'rabbit'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 75, 'rabbit'), ('NCBITaxon_10088', 'Mus <genus>', 87, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 93, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 141, 'antibodies'), ('PR_000000037', 'BMP receptor type-2', 167, '-1'), ('PR_000016500', 'tenomodulin', 178, 'Tom-20'), ('GO_0032991', 'protein-containing complex', 193, 'complexes'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 215, 'Drp-1'), ('PR_000013508', 'PX domain-containing protein kinase-like protein', 222, 'Pink-1'), ('PR_000009691', 'protein LBH', 230, 'LC3A'), ('PR_000012523', 'pancreas/duodenum homeobox protein 1', 248, 'Parkin'), ('GO_0010467', 'gene expression', 316, 'expression')]
PMC5337314	2/2017	S28-PMC5337314	['this Autosomal recessive bleeding disorder is caused by a deficiency of or abnormality in the Platelet Membrane Glycoproteins Iib or Iiia (Gpiib/Iiia).']	N/A	N/A	[('GO_0030849', 'autosome', 5, 'autosomal'), ('CL_0000233', 'platelet', 94, 'platelet'), ('GO_0016020', 'membrane', 103, 'membrane'), ('CHEBI_17089', 'glycoprotein', 112, 'glycoproteins'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 126, 'IIb'), ('PR_000008977', 'elongator complex protein 1', 133, 'IIIa'), ('PR_000008210', 'glutathione peroxidase 1', 139, 'GPIIb'), ('PR_000008977', 'elongator complex protein 1', 145, 'IIIa')]
PMC5372860	2/2017	S101-PMC5372860	['following uptake of Long-Chain polyunsaturated Fatty Acids into Cell Phospholipid Membranes, signaling events activate the cleavage of these Lipids from the Membrane to serve as substrates for the Biosynthesis Of Signaling Molecules [37,38,39].']	N/A	N/A	[('CHEBI_28911', 'cob(III)alamin', 20, 'long-chain'), ('CHEBI_35366', 'fatty acid', 47, 'fatty acids'), ('GO_0005886', 'plasma membrane', 64, 'cell ... membranes'), ('CHEBI_16247', 'phospholipid', 69, 'phospholipid'), ('GO_0007613', 'memory', 82, 'membranes'), ('CHEBI_18059', 'lipid', 141, 'lipids'), ('GO_0016020', 'membrane', 157, 'membrane'), ('GO_0002510', 'central B cell tolerance induction', 197, 'biosynthesis of ... molecules'), ('CHEBI_62488', 'signalling molecule', 213, 'signaling molecules')]
PMC5443512	5/2017	S85-PMC5443512	['the Membranes were blocked with 5% nonfat dry Milk in tris-buffered saline and incubated first with primary Antibodies that recognize Psd95 (1:2000, abcam), Synaptophysin (1:1000, dako) and Insulin Receptor (1:500 santa cruz biotechnology, san diego, ca, usa) overnight at 4°c, and then with their corresponding secondary hrp-conjugated Antibodies.']	N/A	N/A	[('GO_0016020', 'membrane', 4, 'membranes'), ('UBERON_0001913', 'milk', 46, 'milk'), ('GO_0042571', 'immunoglobulin complex, circulating', 108, 'antibodies'), ('GO_0014069', 'postsynaptic density', 134, 'PSD95'), ('PR_000013354', 'pregnancy-specific beta-1-glycoprotein 6', 134, 'PSD95'), ('PR_000015896', 'synaptotagmin-11', 157, 'synaptophysin'), ('PR_000001365', 'interleukin-10 receptor subunit alpha', 190, 'insulin receptor'), ('GO_0042571', 'immunoglobulin complex, circulating', 337, 'antibodies')]
PMC5485039	3/2017	S129-PMC5485039	['in addition to Endogenous Production Of Folate, however, many strains of plasmodium parasites are also capable of utilizing exogenous Folic Acid or Folinic Acid through specialized protein carriers across the Erythrocyte Membrane and across the Membranes of the parasitophorous Vacuole and the parasite (krungkrai et\xa0al ,1990; wang,1999; nzila et\xa0al ,2005).']	N/A	N/A	[('GO_0009790', 'embryo development', 15, 'endogenous'), ('GO_0006412', 'translation', 26, 'production of folate'), ('CHEBI_30863', '5-azaorotic acid', 40, 'folate'), ('CHEBI_30751', 'formic acid', 134, 'folic acid'), ('CHEBI_24068', 'fluoroamino acid', 148, 'folinic acid'), ('CL_0000232', 'erythrocyte', 209, 'erythrocyte'), ('GO_0016020', 'membrane', 221, 'membrane'), ('GO_0016020', 'membrane', 245, 'membranes'), ('GO_0005773', 'vacuole', 278, 'vacuole')]
PMC5485170	3/2017	S30-PMC5485170	['for example, nicotinamide adenine dinucleotide phosphate‐oxidase (nadph oxidase) is a Membrane‐bound enzyme Complex found in Phagosomes, the Vesicles formed by Neutrophils to engulf pathogens as part of the Phagocytic process.']	N/A	N/A	[('GO_0016020', 'membrane', 86, 'membrane'), ('GO_0032991', 'protein-containing complex', 108, 'complex'), ('GO_0000133', 'polarisome', 125, 'phagosomes'), ('GO_0031982', 'vesicle', 141, 'vesicles'), ('CL_0000775', 'neutrophil', 160, 'neutrophils'), ('GO_0006909', 'phagocytosis', 207, 'phagocytic')]
PMC5486026	6/2017	S156-PMC5486026	['western blotting analyses\nprotein extracts (30 µg from Placenta and 20 µg from bewo cells) were resolved on 12% polyacrylamide gels, and transferred onto Polyvinylidene Difluoride Membranes (millipore, billerica, ma, usa).']	N/A	N/A	[('UBERON_0001987', 'placenta', 55, 'placenta'), ('CHEBI_53245', 'poly(vinylpyridine)', 154, 'polyvinylidene difluoride'), ('GO_0016020', 'membrane', 180, 'membranes')]
PMC5486026	6/2017	S157-PMC5486026	['Membranes were incubated with primary Antibodies overnight at 4 °c.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 38, 'antibodies')]
PMC5519748	7/2017	S136-PMC5519748	['thirty microgram of Liver protein extracts were heated for 7\u2009min at 95\u2009°c and then subjected to 10% Sds-page gels using the bio-rad mini protean ii system, and proteins were electroblotted onto Polyvinylidene Difluoride Membranes (0.2 μm pore size, catalog no.']	N/A	N/A	[('UBERON_0002107', 'liver', 20, 'liver'), ('CHEBI_8984', 'sodium dodecyl sulfate', 100, 'SDS'), ('CHEBI_53245', 'poly(vinylpyridine)', 194, 'polyvinylidene difluoride'), ('GO_0016020', 'membrane', 220, 'membranes')]
PMC5526977	7/2017	S20-PMC5526977	['Erα Signaling functions through Nuclear-initiated and Membrane-Initiated signaling.']	N/A	N/A	[('GO_0038127', 'ERBB signaling pathway', 0, 'ERα signaling'), ('PR_000007120', 'ephrin type-A receptor 1', 0, 'ERα'), ('GO_0005634', 'nucleus', 32, 'nuclear'), ('GO_0010075', 'regulation of meristem growth', 54, 'membrane-initiated'), ('GO_0016020', 'membrane', 54, 'membrane')]
PMC5526977	7/2017	S22-PMC5526977	['Erα can also activate Membrane-initiated signaling Cascades (mapk, plc, pi3k) to Modulate cell physiology and Control Gene Expression23–28.']	N/A	N/A	[('PR_000007120', 'ephrin type-A receptor 1', 0, 'ERα'), ('GO_0016020', 'membrane', 22, 'membrane'), ('GO_0055097', 'high density lipoprotein particle mediated signaling', 51, 'cascades'), ('GO_0065007', 'biological regulation', 81, 'modulate'), ('GO_0065007', 'biological regulation', 110, 'control'), ('GO_0010467', 'gene expression', 118, 'gene expression23'), ('SO_0000704', 'gene', 118, 'gene')]
PMC5526977	7/2017	S23-PMC5526977	['the restoration of ere-independent signaling (both Membrane- and Nuclear-initiated) in Erα ko female Mice normalizes Energy Homeostasis.']	N/A	N/A	[('GO_0016020', 'membrane', 51, 'membrane'), ('GO_0005634', 'nucleus', 65, 'nuclear'), ('PR_000007120', 'ephrin type-A receptor 1', 87, 'ERα'), ('NCBITaxon_10088', 'Mus <genus>', 101, 'mice'), ('GO_0097009', 'energy homeostasis', 117, 'energy homeostasis')]
PMC5526977	7/2017	S24-PMC5526977	['these females, called Erα kiko, Express an Erα that does not bind to ere but retains Nuclear-initiated tethered transcriptional Regulation and Membrane-initiated activation of signaling cascades.']	N/A	N/A	[('PR_000007120', 'ephrin type-A receptor 1', 22, 'ERα'), ('GO_0010467', 'gene expression', 32, 'express'), ('PR_000007120', 'ephrin type-A receptor 1', 43, 'ERα'), ('GO_0005634', 'nucleus', 85, 'nuclear'), ('GO_0065007', 'biological regulation', 128, 'regulation'), ('GO_0016020', 'membrane', 143, 'membrane')]
PMC5580292	9/2017	S60-PMC5580292	['Membranes were blocked 1\xa0h in Tris-buffered saline containing 5% nonfat-dried Milk at room temperature.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('CHEBI_9754', 'tris', 30, 'Tris'), ('UBERON_0001913', 'milk', 78, 'milk')]
PMC5580292	9/2017	S61-PMC5580292	['Membranes were then incubated overnight at 4\xa0°c in blocking buffer containing primary Antibodies (as shown in table3).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 86, 'antibodies')]
PMC5718612	12/2017	S174-PMC5718612	['moreover, the Arsenic resistant system (arsrbc), when working, by reducing as(v) into as(Iii) via a Cytoplasmic Arsenate reductase (Arsc) and extruding the latter from the cellular compartment by means of a Membranous as(iii) efflux pump (Arsb).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 14, 'arsenic'), ('CHEBI_16382', 'iodide', 89, 'III'), ('GO_0005737', 'cytoplasm', 100, 'cytoplasmic'), ('CHEBI_29125', 'arsenate(3-)', 112, 'arsenate'), ('PR_000004155', 'apolipoprotein E', 132, 'ArsC'), ('GO_0016020', 'membrane', 207, 'membranous'), ('PR_000004155', 'apolipoprotein E', 239, 'ArsB')]
PMC5804559	10/2017	S96-PMC5804559	['caption (table-wrap): table 4:\n\nfunctional annotation clustering (fac) as performed in davidannotation categorytermenrichment scoregeneflybase Gene idfunction p -value of anovasignificance of anovainterproimmunoglobulin-like Domain/fold11.42meshfbgn0051004ig fold0.000611***ppnfbgn0003137ig Domain, Extracellular Matrix structural constituent0.0101*interpro/go_term_bp_direct/goterm_mf_directproteolysis, peptidase6.16jon65aifbgn0035667serine-type endopeptidase, proteolysis0.00293**mp1fbgn0027930serine-type endopeptidase, Proteolysis0.00187**thetatryfbgn0011555digestive enzyme with serine-type peptidase activity1.68e-08***zetatryfbgn0011556digestive enzyme with serine-type peptidase activity0.000488***decayfbgn0028381cysteine-type endopeptidase activity, caspase0.00188**dammfbgn0033659cysteine-type endopeptidase activity, caspase6.79e-06***alphatryfbgn0003863serine-type endopeptidase, Proteolysis5.69e-05***ser7fbgn0019929serine-type endopeptidase, Proteolysis1.51e-12***ser6fbgn0011834serine-type endopeptidase, Proteolysis5.17e-03**Swimfbgn0034709Polysaccharide binding, cysteine-type peptidase activity, Proteolysis1.35e-02*jon74efbgn0023197serine-type endopeptidase, Proteolysis1.58e-03**pshfbgn0030926peptidase and serine-type endopeptidase activity, Defense response4.41e-08***jon65aivfbgn0250815serine-type endopeptidase, Proteolysis1.74e-04***jon65aiiifbgn0035665serine-type endopeptidase, Proteolysis6.77e-05***ance-4fbgn0033366peptidase6.97e-04***ancefbgn0012037peptidyl-dipeptidase activity6.97e-04***jon25biifbgn0031654serine-type endopeptidase, Proteolysis8.62e-04***goerm_bp_direct/interpro/goterm_mf_directg-protein-coupled receptor signalling, Rhodopsin-Like6.02rh3fbgn0003249g-protein coupled Photoreceptor activity3.73e-03**akhrfbgn0025595ccarbohydrate, Lipid and Tryglyceride Homeostasis1.88e-09***rh2fbgn0003248g-protein coupled Photoreceptor activity4.65e-02*galphasfbgn0001123signal transduction, chemical Synaptic Transmission1.07e-11***Ninaefbgn0002940G-protein coupled Photoreceptor activity, Rhodopsin-Like2.80e-05***ggamma1fbgn0004921g-Protein, Gamma Subunit, signal transducer activity4.16e-05***Gbeta76Cfbgn0004623G-protein coupled Photoreceptor activity2.71e-02*rh4fbgn0003250g-protein coupled Photoreceptor activity1.83e-03**goterm_mf_direct/goterm_bp_directfatty Acid elongation3.49eloffbgn0037762fatty Acid elongase4.60e-05***goterm_mf_directneuropeptide hormone activity/binding3.35nplp2fbgn0040813neuropeptide Signaling, Humoral Immune Response1.39e-02*nplp3fbgn0042201neuropeptide hormone activity, neuropeptide signaling3.45e-01nsneb-cgpfbgn0083167hormone activity, Regulation of growth3.72e-02*goterm_mf/cc/bp_directcalcium-dependent Phospholipid binding2.72anxb9fbgn0000083calcium Ion binding, calcium-dependent Phospholipid binding7.69e-03**gpterm_mp_direct, interpro, cog_ontologycalcium Ion binding, signal transduction, ef-hand Domain2.5calsfbgn0039928calcium Ion binding, chemical Synaptic Transmission2.29e-02*gelfbgn0010225actin binding, Calcium Ion binding1.52e-03**Scp2Fbgn0020907Calcium Ion binding3.43e-02*Scp1Fbgn0020908Calcium Ion binding8.74e-02.mlc2fbgn0002773calcium Ion binding3.33e-04***zasp52fbgn0265991muscle development3.91e-08***lpr1fbgn0066101uptake of neutral Lipids from circulation, Calcium Ion binding4.93e-01nsmlc1fbgn0002772calcium Ion binding, myosin3.91e-04***upfbgn0004169calcium Ion binding, Calcium Ion homeostatis, Muscle Morphogenesis3.26e-04***Tpnc73Ffbgn0010424Calcium Ion binding3.01e-10***Gpo-1fbgn0022160glycerol-3-Phosphate dehydrogenase activity, Calcium Ion binding0.000209***interpro, goterm_mf/bp/cc_directfatty Acyl-Coa reductase, Peroxisome2.47watfbgn0039620long-chain-fatty-acyl-coa reductase activity, oxidation-reduction process1.21e-06***spatfbgn0014031amino transferase activity, glyoxylate Catabolic Process, proxisome2.02e-02*catfbgn0000261catalase, antioxidant activity and Ros Metabolic Process1.15e-02*urofbgn0003961urate oxidase activity, Oxidation-reduction process, Peroxisome1.96e-02*acox57d-dfbgn0034629acyl-coa dehydrogenase activity, Fatty Acid Beta-Oxidation, Peroxisome4.63e-05***goterm_mf/bp/cc_direct, interprooxidation−reduction, haeme binding, Iron Ion binding, Cytochrome p4502.2menfbgn0002719malic oxidoreductase, determination of Adult Lifespan5.16e-04***cyp6a23fbgn0033978cytochrome p450, Heme and Iron Ion binding, oxidation-reduction process4.93e-01nscyp4p1fbgn0015037cytochrome P450, Heme and Iron Ion binding, oxidation-reduction process7.98e-02.cprfbgn0015623nadph-hemoprotein reductase activity, Oxidation-reduction process2.27e-04***cyt-b5-rfbgn0000406heme binding, oxidoreductase activity, Lipid Metabolic Process2.69e-04***Antdhfbgn0026268Oxidoreductase activity, oxidation-reduction process4.85e-02*aox1fbgn0267408aldehyde oxidase, Pyridoxal oxidase activity5.82e-03**cyt-b5fbgn0264294cytocrome B5-like Heme-Binding Site6.47e-04***cyp313a1fbgn0038236cytochrome P450, Heme and Iron Ion binding, Oxidation-reduction process1.45e-02*mt: coifbgn0013674mitochondrial Cytochrome C oxidase, Heme and iron binding7.39e-02.aldhfbgn0012036aldehyde dehydrogenase, oxidation-reduction9.39e-03**Cyp4E3Fbgn0015035Cytochrome P450, Heme and Iron Ion binding, oxidation-reduction process1.27e-05***hgofbgn0040211homogentisate 1, 2-Dioxygenase activity, Oxidation-reduction process4.08e-03**Pdhfbgn0011693Retinol and Alcohol dehydrogenase activity, Oxidation-reduction process4.75e-03**desat1fbgn0086687fatty Acid desaturase, Oxidation-reduction process2.55e-05***plodfbgn0036147iron Ion binding, oxidoreductase activity, oxidation-reduction process6.75e-04***fad2fbgn0029172fatty Acid desaturase, oxidation-reduction process, Lipid Metabolic Process1.15e-03**gpdhfbgn0001128carbohydrate Metabolic Process, oxidation-reduction process6.13e-04***goterm_bp/cc/mf_directcalcium Ion channel, Transmembrane transport2.13trplfbgn0005614calcium channel activity, calcium Ion transport2.13e-02*trpfbgn0003861plasma Membrane Cation channel, calcium channel3.06e-09***goterm_bp/cc/mf_directvoltage-gated potassium channel activity2.03irk3fbgn0032706potassium channel activity, potassium Ion transport3.88e-02*kegg_pathway, interpro, goterm_bp/cc/mf_directfatty Acid Metabolism/biosynthetic process1.93accfbgn0033246acetyl-coa carboxylase activity, Fatty Acid Biosybthetic process3.44e-03**cyt-b5-rfbgn0000406cytochrome B5-like Heme binding, Lipid Metabolic Process6.47e-04***desat1fbgn0086687fatty Acid desaturase, oxidation-reduction process2.55e-05***fad2fbgn0029172fatty Acid desaturase, oxidation-reduction process, Lipid Metabolic Process1.15e-03**acslfbgn0263120long-Chain Fatty Acid-Coa ligase activity1.03e-04***interpro, goterm_mf_directcarbohydrate binding1.91clect27fbgn0031629carbohydrate binding4.40e-11***lectin-37dbfbgn0053533galactose binding2.68e-04***interpro, goterm_mf_directpotassium Ion Transport, Oxalate Transmembrane transporter activity1.65irk3fbgn0032706potassium channel activity, potassium Ion transport3.88e-02*irk2fbgn0039081potassium channel activity, potassium Ion transport1.96e-08***dic1fbgn0027610inorganic Phosphate Transmembrane transporter activity3.33e-05***goterm_mf/bp/cc_direct, interproneurotransmitter-gated Ion-channel ligand binding1.45calsfbgn0039928calcium Ion binding2.29e-02*goterm_mf/bp/cc_direct, interpro, cog_ontologyreceptor activity, carboxylesterase, Lipid Metabolism1.35alpha-est7fbgn0015575carboxylic Ester hydrolase activity, Lipid Storage, determination of Lifespan2.49e-04***accfbgn0033246acetyl-coa carboxylase activity, Fatty Acid Biosybthetic Process3.44e-03**gs2fbgn0001145glutamate Catabolic Process, Neurotransmitter receptor Metabolic process1.46e-03**est-6fbgn0000592carboxylic Ester hydrolase activity2.93e-02*accoasfbgn0012034acetyl-coa ligase activity3.35e-04***goterm_mf/bp/cc_direct, interproneurotransmitter transporter1.32naat1fbgn0029762neurotransmitter transporter activity2.06e-08***eaat1fbgn0026439glutamate: sodium symporter activity, determination of Adult Lifespan2.06e-02*\nGenes that were significantly down-regulated in these data in hplc compared to lphc were compared to a background list of Genes that were Expressed and detected in these data.']	N/A	N/A	[('SO_0000704', 'gene', 143, 'gene'), ('SO_0000417', 'polypeptide_domain', 225, 'domain'), ('SO_0000417', 'polypeptide_domain', 291, 'domain'), ('GO_0031012', 'extracellular matrix', 299, 'extracellular matrix'), ('GO_0006508', 'proteolysis', 524, 'proteolysis0'), ('GO_0006412', 'translation', 894, 'proteolysis5'), ('GO_0006412', 'translation', 958, 'proteolysis1'), ('GO_0006412', 'translation', 1022, 'proteolysis5'), ('PR_000015393', 'suppressor of cytokine signaling 2', 1043, 'SwimFBgn0034709Polysaccharide'), ('GO_0006412', 'translation', 1116, 'proteolysis1'), ('GO_0006412', 'translation', 1180, 'proteolysis1'), ('GO_0006952', 'defense response', 1265, 'defense'), ('GO_0006412', 'translation', 1338, 'proteolysis1'), ('GO_0006508', 'proteolysis', 1407, 'proteolysis6'), ('GO_0006412', 'translation', 1567, 'proteolysis8'), ('PR_000013940', 'repulsive guidance molecule A', 1669, 'rhodopsin-like6'), ('CL_0000210', 'photoreceptor cell', 1719, 'photoreceptor'), ('CHEBI_18059', 'lipid', 1781, 'lipid'), ('CHEBI_17855', 'triglyceride', 1791, 'tryglyceride'), ('GO_0042592', 'homeostatic process', 1804, 'homeostasis1'), ('CL_0000210', 'photoreceptor cell', 1858, 'photoreceptor'), ('GO_0007416', 'synapse assembly', 1937, 'synaptic transmission1'), ('GO_0045202', 'synapse', 1937, 'synaptic'), ('PR_000011271', 'NACHT, LRR and PYD domains-containing protein 3', 1969, 'ninaEFBgn0002940G'), ('CL_0000210', 'photoreceptor cell', 2003, 'photoreceptor'), ('PR_000001855', 'fractalkine', 2027, 'rhodopsin-like2'), ('PR_000014700', 'serpin B9', 2072, 'protein, gamma subunit'), ('PR_000035364', 'histone H3-like centromeric protein A, initiator methionine removed phosphorylated 1 (human)', 2133, 'Gbeta76CFBgn0004623G'), ('CL_0000210', 'photoreceptor cell', 2170, 'photoreceptor'), ('CL_0000210', 'photoreceptor cell', 2233, 'photoreceptor'), ('CHEBI_37527', 'acid', 2304, 'acid'), ('CHEBI_37527', 'acid', 2344, 'acid'), ('GO_0023051', 'regulation of signaling', 2454, 'signaling'), ('GO_0003017', 'lymph circulation', 2465, 'humoral immune response1'), ('UBERON_0002405', 'immune system', 2473, 'immune'), ('GO_0065007', 'biological regulation', 2612, 'regulation'), ('CHEBI_16247', 'phospholipid', 2681, 'phospholipid'), ('CHEBI_24870', 'ion', 2729, 'ion'), ('CHEBI_16247', 'phospholipid', 2760, 'phospholipid'), ('CHEBI_24870', 'ion', 2838, 'ion'), ('SO_0000417', 'polypeptide_domain', 2880, 'domain2'), ('CHEBI_24870', 'ion', 2912, 'ion'), ('GO_0007608', 'sensory perception of smell', 2934, 'synaptic transmission2'), ('GO_0045202', 'synapse', 2934, 'synaptic'), ('CHEBI_39124', 'calcium ion', 2993, 'calcium ion'), ('PR_000029773', 'ankyrin repeat domain-containing protein SOWAHB', 3022, 'Scp2FBgn0020907Calcium'), ('CHEBI_24870', 'ion', 3045, 'ion'), ('PR_000029775', 'histidine--tRNA ligase, mitochondrial', 3065, 'Scp1FBgn0020908Calcium'), ('CHEBI_24870', 'ion', 3088, 'ion'), ('CHEBI_24870', 'ion', 3131, 'ion'), ('CHEBI_18059', 'lipid', 3232, 'lipids'), ('CHEBI_39124', 'calcium ion', 3257, 'calcium ion'), ('CHEBI_24870', 'ion', 3309, 'ion'), ('CHEBI_24870', 'ion', 3360, 'ion'), ('CHEBI_39124', 'calcium ion', 3373, 'calcium ion'), ('GO_0000278', 'mitotic cell cycle', 3398, 'muscle morphogenesis3'), ('PR_000021909', 'TGF-beta 2 isoform B, signal peptide removed form', 3429, 'TpnC73FFBgn0010424Calcium'), ('CHEBI_24870', 'ion', 3455, 'ion'), ('PR_000007898', 'glutamate--cysteine ligase regulatory subunit', 3477, 'Gpo'), ('CHEBI_15588', '(R)-malate(2-)', 3501, '-3-phosphate'), ('CHEBI_39124', 'calcium ion', 3538, 'calcium ion'), ('CHEBI_17984', 'acyl-CoA', 3606, 'acyl-CoA'), ('GO_0005777', 'peroxisome', 3626, 'peroxisome2'), ('GO_0009056', 'catabolic process', 3792, 'catabolic process'), ('CHEBI_8756', 'RNA (poly(A))', 3878, 'ROS'), ('GO_0006401', 'RNA catabolic process', 3878, 'ROS metabolic process1'), ('GO_0045732', 'positive regulation of protein catabolic process', 3946, 'oxidation-'), ('GO_0005777', 'peroxisome', 3975, 'peroxisome1'), ('CHEBI_35366', 'fatty acid', 4047, 'fatty acid'), ('GO_0006635', 'fatty acid beta-oxidation', 4047, 'fatty acid beta-oxidation'), ('GO_0005777', 'peroxisome', 4074, 'peroxisome4'), ('CHEBI_24870', 'ion', 4163, 'iron ion'), ('CHEBI_4056', 'cytochrome', 4181, 'Cytochrome'), ('UBERON_0007023', 'adult organism', 4252, 'adult'), ('UBERON_0000104', 'life cycle', 4258, 'lifespan5'), ('CHEBI_30413', 'heme', 4312, 'heme'), ('CHEBI_24870', 'ion', 4321, 'iron ion'), ('PR_000001900', 'neuropilin-1', 4404, 'P450'), ('CHEBI_30413', 'heme', 4410, 'heme'), ('CHEBI_24870', 'ion', 4419, 'iron ion'), ('GO_0045732', 'positive regulation of protein catabolic process', 4525, 'oxidation-'), ('CHEBI_18059', 'lipid', 4621, 'lipid'), ('GO_0002449', 'lymphocyte mediated immunity', 4621, 'lipid metabolic process2'), ('PR_000029120', 'cGMP-dependent protein kinase 1', 4655, 'antdhFBgn0026268Oxidoreductase'), ('CHEBI_17310', 'pyridoxal', 4765, 'pyridoxal'), ('PR_000002118', 'voltage-dependent P/Q-type calcium channel subunit alpha-1A', 4828, 'b5'), ('CHEBI_30413', 'heme', 4836, 'heme'), ('SO_0000409', 'binding_site', 4841, 'binding site6'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 4894, 'P450'), ('PR_000001900', 'neuropilin-1', 4894, 'P450'), ('CHEBI_30413', 'heme', 4900, 'heme'), ('CHEBI_24870', 'ion', 4909, 'iron ion'), ('GO_0045732', 'positive regulation of protein catabolic process', 4927, 'oxidation-'), ('CHEBI_18070', 'cytochrome c', 4995, 'Cytochrome C'), ('PR_000006035', 'cathepsin Z', 4995, 'Cytochrome C'), ('CHEBI_30413', 'heme', 5017, 'heme'), ('PR_000027147', 'cyclin B1:Cdk1 complex phosphorylated 5 (human)', 5115, 'Cyp4e3FBgn0015035Cytochrome P450'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 5143, 'P450'), ('CHEBI_30413', 'heme', 5149, 'heme'), ('CHEBI_24870', 'ion', 5158, 'iron ion'), ('CHEBI_50971', '[4]pseudorotaxane', 5247, 'dioxygenase'), ('GO_0015671', 'oxygen transport', 5269, 'oxidation'), ('PR_000001655', 'prostacyclin receptor', 5306, 'PdhFBgn0011693Retinol'), ('CHEBI_30879', 'alcohol', 5332, 'alcohol'), ('GO_0015671', 'oxygen transport', 5364, 'oxidation'), ('CHEBI_37527', 'acid', 5424, 'acid'), ('GO_0045732', 'positive regulation of protein catabolic process', 5441, 'oxidation-'), ('CHEBI_24870', 'ion', 5499, 'ion'), ('CHEBI_37527', 'acid', 5596, 'acid'), ('CHEBI_18059', 'lipid', 5642, 'lipid'), ('GO_0010352', 'lithium ion export across the plasma membrane', 5642, 'lipid metabolic process1'), ('GO_0008152', 'metabolic process', 5703, 'metabolic process'), ('CHEBI_24870', 'ion', 5790, 'ion'), ('GO_0042651', 'thylakoid membrane', 5803, 'transmembrane'), ('CHEBI_24870', 'ion', 5879, 'ion'), ('GO_0016020', 'membrane', 5922, 'membrane'), ('CHEBI_36916', 'cation', 5931, 'cation'), ('CHEBI_24870', 'ion', 6092, 'ion'), ('CHEBI_37527', 'acid', 6166, 'acid'), ('GO_0043443', 'acetone metabolic process', 6166, 'acid metabolism'), ('CHEBI_35366', 'fatty acid', 6253, 'fatty acid'), ('GO_0006633', 'fatty acid biosynthetic process', 6253, 'fatty acid biosybthetic'), ('PR_000002118', 'voltage-dependent P/Q-type calcium channel subunit alpha-1A', 6324, 'b5'), ('CHEBI_30413', 'heme', 6332, 'heme'), ('CHEBI_18059', 'lipid', 6346, 'lipid'), ('GO_0006629', 'lipid metabolic process', 6346, 'lipid metabolic process6'), ('CHEBI_37527', 'acid', 6403, 'acid'), ('CHEBI_37527', 'acid', 6479, 'acid'), ('CHEBI_18059', 'lipid', 6525, 'lipid'), ('GO_0010352', 'lithium ion export across the plasma membrane', 6525, 'lipid metabolic process1'), ('CHEBI_80086', 'Onnamide A', 6577, '-chain fatty acid-CoA'), ('CHEBI_24870', 'ion', 6810, 'ion'), ('GO_0006811', 'ion transport', 6810, 'ion transport'), ('CHEBI_16162', 'o-orsellinate', 6825, 'oxalate'), ('GO_0009294', 'DNA mediated transformation', 6833, 'transmembrane'), ('GO_0042651', 'thylakoid membrane', 6833, 'transmembrane'), ('CHEBI_24870', 'ion', 6924, 'ion'), ('CHEBI_24870', 'ion', 6999, 'ion'), ('CHEBI_18367', 'phosphate(3-)', 7048, 'phosphate'), ('GO_0042651', 'thylakoid membrane', 7058, 'transmembrane'), ('CHEBI_24870', 'ion', 7158, 'ion'), ('CHEBI_24870', 'ion', 7211, 'ion'), ('CHEBI_18059', 'lipid', 7314, 'lipid'), ('GO_0002088', 'lens development in camera-type eye', 7314, 'lipid metabolism1'), ('CHEBI_35701', 'ester', 7366, 'ester'), ('CHEBI_18059', 'lipid', 7392, 'lipid'), ('GO_0019915', 'lipid storage', 7392, 'lipid storage'), ('UBERON_0000104', 'life cycle', 7424, 'lifespan2'), ('CHEBI_35366', 'fatty acid', 7490, 'fatty acid'), ('GO_0006633', 'fatty acid biosynthetic process', 7490, 'fatty acid biosybthetic process3'), ('GO_0009056', 'catabolic process', 7555, 'catabolic process'), ('CHEBI_25512', 'neurotransmitter', 7574, 'neurotransmitter'), ('GO_0008152', 'metabolic process', 7600, 'metabolic'), ('CHEBI_35701', 'ester', 7654, 'ester'), ('UBERON_0007023', 'adult organism', 7940, 'adult'), ('UBERON_0000104', 'life cycle', 7946, 'lifespan2'), ('SO_0000704', 'gene', 7964, 'Genes'), ('SO_0000704', 'gene', 8086, 'genes'), ('GO_0010467', 'gene expression', 8102, 'expressed')]
PMC5804559	10/2017	S98-PMC5804559	['caption (table-wrap): table 5:\n\na functional annotation comparison of up and downregulated Genes at each generationf0f1f2f3go categorygo term n \u2009=\u20091074 n \u2009=\u20091867 n \u2009=\u2009541 n \u2009=\u20091684 n \u2009=\u200917 n \u2009=\u200922 n \u2009=\u20091893 n \u2009=\u20092720↑ Expression in hplc↓ Expressison in hplc↓ Expression in mm↑ Expression in mm↓ Expression in mm↑ Expression in mm↓ Expression in mm↑ Expression in mm Biological Process# Genes % of total # Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes % of total\u2003biological adhesiongo: 002261030.30341.9010.20291.9017.1070.40351.50\u2003biological Regulationgo: 0065007807.601277.00255.101097.2014.501437.501757.40\u2003cellular component organization or biogenesisgo: 0071840938.90633.50367.30513.4014.501769.20984.10\u2003Cellular processgo: 000998737035.3047526.3016433.5038325.50214.30418.2069636.3060225.50\u2003developmental processgo: 0032502373.501045.80112.20895.9029.10703.601476.20\u2003Immune System processgo: 0002376101.00261.4051.00251.70160.80331.40\u2003localizationgo: 0051179787.401397.70255.101308.60214.3029.101517.901948.20\u2003Locomotiongo: 004001140.4010.1020.4010.1060.3010.00\u2003Metabolic processgo: 000815238336.5039321.8017936.5032821.80535.70522.7070836.9050821.50\u2003multicellular Organismal processgo: 0032501181.701277.0061.20906.0029.10281.501626.90\u2003reproductiongo: 0000003161.50301.7091.80241.6014.50281.50361.50\u2003response to stimulusgo: 0050896757.201246.90336.701067.0014.501407.301667.00\u2003Rhythmic processgo: 0048511140.8010.20130.9014.5010.10140.60 protein class# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total \u2003Calcium-Binding proteinpc0006040.40271.5010.20140.90170.90351.50\u2003Cell Adhesion Moleculepc0006920.20241.30161.1050.30301.30\u2003Cell Junction proteinpc0007030.30%80.40100.7050.30140.60\u2003chaperonepc0007280.80%30.2020.40%30.20140.7070.30\u2003Cytoskeletal proteinpc00085413.90%442.40173.50%382.50593.10592.50\u2003defense/immunity proteinpc0009020.20%80.4010.20%70.5070.40100.40\u2003enzyme modulatorpc00095424.00%593.30142.90%513.4014.50%1015.30723.00\u2003Extracellular Matrix proteinpc00102221.20161.1030.20261.10\u2003hydrolasepc00121737.00%1448.00306.10%1318.70428.60%29.10%1427.401817.70\u2003isomerasepc0013550.50%50.3080.50130.7070.30\u2003ligasepc00142242.30%201.1081.60%151.0017.10%14.50%482.50251.10\u2003lyasepc0014440.40%281.60201.30150.80251.10\u2003Membrane Traffic proteinpc0015060.60%160.90151.00140.70210.90\u2003Nucleic Acid bindingpc0017116415.60%724.008818.00%604.0029615.401345.70\u2003oxidoreductasepc00176212.00%945.20122.40%674.50432.20964.10\u2003receptorpc00197121.10%814.5051.00%644.3017.10%281.501074.50\u2003signalling Moleculepc00207121.10%563.1030.60%493.3014.50%241.30723.00\u2003storage proteinpc0021030.30%70.4020.40%40.3050.3080.30\u2003structural proteinpc0021120.2020.1010.2030.2070.4030.10\u2003transcription factorpc00218817.70683.80336.70%593.901306.801175.00\u2003transfer/carrier proteinpc00219131.20%362.0010.20%312.10281.50512.20\u2003transferasepc00220625.90%563.10255.10%493.3014.50%1316.80662.80\u2003Transmembrane receptor Regulatory/adaptor proteinpc0022610.10%60.3081.60%40.3030.2050.20\u2003transporterpc00227282.70%1407.801087.20472.501687.10\u2003Viral proteinpc0023710.10 molecular function# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total \u2003antioxidant activitygo: 001620920.2090.5030.6070.5050.30120.50\u2003bindinggo: 000548825824.6024013.3011723.9020113.4017.10%14.50%45523.7034914.80\u2003catalytic activitygo: 000382426525.3041222.8012325.1035223.40%535.70%418.20%52427.3048320.40\u2003channel regulator activitygo: 001624710.00\u2003receptor activitygo: 000487280.80543.0051.00473.1017.10180.90743.10\u2003signal transducer activitygo: 000487130.30120.7010.2080.5070.40190.80\u2003structural Molecule activitygo: 0005198222.10643.5061.20442.90452.30873.70\u2003Translation regulator activitygo: 004518220.2010.1010.201157.6090.5030.10\u2003transporter activitygo: 0005215343.201498.30132.7017.1014.50583.001777.50\nup- and down-regulated Genes at each generation were submitted to panther for an analysis of their annotated function.']	N/A	N/A	[('SO_0000704', 'gene', 91, 'genes'), ('GO_0010467', 'gene expression', 218, 'expression'), ('GO_0010467', 'gene expression', 238, 'expressison'), ('GO_0010467', 'gene expression', 259, 'expression'), ('GO_0010467', 'gene expression', 277, 'expression'), ('GO_0010467', 'gene expression', 295, 'expression'), ('GO_0010467', 'gene expression', 313, 'expression'), ('GO_0010467', 'gene expression', 331, 'expression'), ('GO_0010467', 'gene expression', 349, 'expression'), ('GO_0006915', 'apoptotic process', 366, 'Biological process'), ('SO_0000704', 'gene', 386, 'genes'), ('SO_0000704', 'gene', 405, 'genes'), ('SO_0000704', 'gene', 422, 'genes'), ('SO_0000704', 'gene', 439, 'genes'), ('SO_0000704', 'gene', 456, 'genes'), ('SO_0000704', 'gene', 473, 'genes'), ('SO_0000704', 'gene', 490, 'genes'), ('SO_0000704', 'gene', 507, 'genes'), ('GO_0050818', 'regulation of coagulation', 604, 'regulationGO'), ('GO_0007049', 'cell cycle', 770, 'Cellular'), ('UBERON_0002410', 'autonomic nervous system', 934, 'Immune system'), ('GO_0061440', 'kidney vasculature development', 1077, 'LocomotionGO'), ('GO_0008152', 'metabolic process', 1129, 'Metabolic'), ('NCBITaxon_1', 'root', 1232, 'organismal'), ('GO_0046334', 'octopamine catabolic process', 1445, 'Rhythmic'), ('SO_0000704', 'gene', 1521, 'genes'), ('SO_0000704', 'gene', 1538, 'genes'), ('SO_0000704', 'gene', 1555, 'genes'), ('SO_0000704', 'gene', 1572, 'genes'), ('SO_0000704', 'gene', 1589, 'genes'), ('SO_0000704', 'gene', 1606, 'genes'), ('SO_0000704', 'gene', 1623, 'genes'), ('SO_0000704', 'gene', 1640, 'genes'), ('CHEBI_31341', 'calcium dihydroxide', 1657, 'Calcium'), ('PR_000010000', 'lysozyme g-like protein 2', 1664, '-binding'), ('PR_000009339', 'killer cell immunoglobulin-like receptor 3DL3', 1722, 'Cell adhesion moleculePC0006920'), ('CHEBI_53706', 'phenoxymethylpenicillanyl group', 1736, 'moleculePC0006920'), ('GO_0030054', 'cell junction', 1780, 'Cell junction'), ('GO_0005856', 'cytoskeleton', 1887, 'Cytoskeletal'), ('GO_0031012', 'extracellular matrix', 2087, 'Extracellular matrix'), ('GO_0016020', 'membrane', 2368, 'Membrane'), ('GO_0055085', 'transmembrane transport', 2368, 'Membrane traffic'), ('CHEBI_17497', 'glycolic acid', 2430, 'Nucleic acid'), ('GO_0005634', 'nucleus', 2430, 'Nucleic'), ('CHEBI_53726', 'procion red MX-5B', 2633, 'moleculePC00207121'), ('GO_0032588', 'trans-Golgi network membrane', 3003, 'Transmembrane'), ('GO_0065007', 'biological regulation', 3026, 'regulatory'), ('NCBITaxon_10088', 'Mus <genus>', 3145, 'Viral'), ('SO_0000704', 'gene', 3191, 'genes'), ('SO_0000704', 'gene', 3208, 'genes'), ('SO_0000704', 'gene', 3225, 'genes'), ('SO_0000704', 'gene', 3242, 'genes'), ('SO_0000704', 'gene', 3259, 'genes'), ('SO_0000704', 'gene', 3276, 'genes'), ('SO_0000704', 'gene', 3293, 'genes'), ('SO_0000704', 'gene', 3310, 'genes'), ('CHEBI_36357', 'polyatomic entity', 3754, 'molecule'), ('GO_0006412', 'translation', 3818, 'Translation'), ('SO_0000704', 'gene', 3989, 'genes')]
